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ABSTRACT 
Pevey, Ryan Shaun The Differential Expression of Gene Cohorts Over the Course of 
Development in Type I and Type II Layer V Pyramidal Neurons of the Mouse 
Medial Prefrontal and Primary Somatosensory Cortex. Unpublished Master of 
Science thesis, University of Northern Colorado, 2017. 
Two of the most challenging problems in neuroscience may be the characterization of 
different neuron types and determining the various decision points over the course of 
development that defines those different cell types. Part of the problem is that for the 
clear majority of neuron types, no single gene so far has been shown to act as a type 
marker. Instead it seems that signatures involving multiple genes are necessary to define 
each type. The identity of the genes in these signatures remains an important gap in our 
knowledge. However, recent developments in bioinformatics have produced population 
level transcript sequencing of single cell types. These datasets provide a rich resource for 
identifying marker genes for neuronal type and for decoding their developmental timeline 
as well. Here I present a method for analyzing cortical neuron datasets and verifying the 
expression profiles of the identified marker-gene protein products. Type I and Type II 
pyramidal neurons within layer V of the neocortex are important output neurons of the 
neocortical circuit and are associated with several brain disorders such as Schizophrenia, 
Alzheimer’s and some types of Autism. They are found in all regions of the neocortex 
and are defined by their axonal targets; Type I neurons project subcortically while Type 
II neurons project contralaterally. In the mouse, the primary somatosensory cortex is 
probably the most studied region. The less studied medial prefrontal cortex is associated 
 iv 
with executive functions such as working memory and decision making processes. 
Fourteen putative genetic type markers for layer V pyramidal neurons of the mouse 
medial prefrontal and primary somatosensory cortices (seven Type I, seven Type II) were 
identified and eight were assessed for protein expression via fluorescence 
immunohistochemistry at ages P1 and P7. This is the first study assessing the protein 
expression of PCP4 and TCERG1L in Layer V pyramidal neurons in comparison 
between the two brain regions. This is also the first time that PCP4 has been shown to be 
present in Type I neurons of the mouse medial prefrontal cortex or at postnatal ages. 
Ultimately, PCP4 was determined to be a viable Type I marker at both ages and in both 
cortical locations. Finding new marker genes for these neurons is important for 
understanding not only their function and development but also for that of the whole 
neocortex. Once identified, their role in function and development can be determined for 
each neuron type which may help shed light on some of the disorders associated with 
them. 
Keywords: colocalization, contralateral, callosal, cufflinks, FIJI, Icy, Layer 5, Layer V, 
mPFC, marker gene, medial prefrontal, neuronal subtype, P1, P7, PCP4, prefrontal, 
primary somatosensory, pyramidal neuron, SSp, somatosensory, subcortical, TCERG1L, 
tophat, Type I, Type II, Type 1, Type 2  
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CHAPTER I 
INTRODUCTION 
Specific Aims 
This project addresses the gap in our knowledge about the molecular identities of 
two specific pyramidal neuron cell types that reside within layer V of the medial 
prefrontal cortex (mPFC) and primary somatosensory cortex (SSp) of the mouse brain. 
The characteristic difference between these two cell types, designated Type I and Type II, 
is the target of their axonal projections[1]. Type I neurons project their axons 
subcortically to different tissues below the cortex, such as the pons in the brainstem[2]. 
Type II neurons project their axons contralaterally to the same mirror image location in 
the opposite hemisphere of the neocortex[2]. These neuron types are partially 
characterized based on their cellular morphology, their electrical properties, and the 
various contacts that they make with other cells. However, the molecular and 
developmental pathway that determines these characters is still unknown. The goal of this 
project was to identify novel marker signatures for these two cell types, but was also 
importantly to identify functionally important gene clusters that provide insight into the 
physiological differences between the two cell types. 
 
H1 The differential gene expression between Type I and Type II neurons is 
indicative of the physiological and morphological differences between the 
two cell types, with expected gene clusters including genes involved with 
neural development and differentiation. 
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H2 Tissue sections double stained with markers established in the literature 
and the proposed markers, will align with their predicted marker identities 
from Hypothesis 1. 
 
Neocortical Development 
The mammalian neocortex is a very complex tissue with many different cell types 
and connections between them[3]. The development of these cell types are determined by 
a programmatic series of molecular determinants that carry them through to 
maturity[2,3]. The various regions of the neocortex are established relatively early, at 
embryonic day 9.5 (E9.5) in mice, by well-known diffusible morphogens such as Fgf8, 
Wnt’s, Bmp’s, Couptf1 and Sp8[2]. This early regionalization provides a two-dimensional 
coordinate to each cell population and initiates the area specific development associated 
with that region. Each region then later specializes for a specific type of information 
processing, for example audio or visual information. 
At this point in development (E9.5), the mouse neocortical lamina is made up of 
undifferentiated neuroepithelial cells which differentiate into radial glial cells 
establishing a ventricular proliferation zone towards the core of the tissue[2]. The radial 
glial cells have a bipolar morphology with processes that span the entire lamina of the 
developing cortex and are progenitors that produce neurons via asymmetrical cellular 
division[2]. The newly born neurons climb the radial glial processes from the ventricular 
surface to the pial surface in an inside out fashion[2]. In this manner each successive 
round of neurons pushes past the previous ones, creating the layered structure of the 
neocortex[2,4]. There are up to six layers of neurons in the neocortex, with each layer 
specializing for its own function within the neural circuit[5]. The outermost layer, 
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furthest from the ventricle, is denoted layer I and the inner most layer, closest to the 
ventricle, is layer VI. 
Starting at E10.5 the radial glia begin producing the first excitatory neurons, the 
subplate neurons[6]. Around E11.5 the corticothalamic projection neurons, which largely 
constitute layer VI, are beginning to migrate out of the ventricular zone[2]. The birth of 
Type I cells of layer V begins at E12.5 and peaks at E13.5[2]. Type II cells begin to be 
born at E12.5 as well and continue to increase in number until E15.5 with later born 
callosal projection neurons migrating to superficial layers II/III[2]. The birth of layer IV 
neurons start on E14.5, the last layer to start, and they migrate past the layer II/III 
neurons and retreat back to layer IV[2,7]. Not every brain region has a layer IV. For 
example, the primary somatosensory cortex in the mouse does have a layer IV but the 
medial prefrontal cortex does not. 
The primary somatosensory and medial prefrontal cortex are the two brain regions 
that are considered in this project. The primary somatosensory cortex processes 
information from the sense of touch and is one of the most studied regions in the 
neocortex. The less studied medial prefrontal cortex is a higher-order processing center 
associated with executive functions such as decision-making and working memory tasks. 
They are also in separate functional modules within the neocortical connectome[8] which 
might lead to physiological or developmental differences between regions. 
There are some differences in tissue properties between different brain regions[9]. 
For example, the thickness of the individual layers can vary between different regions. 
The differential gene expression of analogous cell types between different regions of the 
neocortex has not been vigorously studied, but there are some notable regionalizations. 
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LIM domain only 4 (Lmo4), for example, is expressed in postmitotic neurons of higher-
order sensory areas and motor cortex; but is absent in primary somatosensory, audio and 
visual cortices[2]. 
We have known about some of these cytoarchitectural regionalizations for over a 
century. Even though there are well known regional differences on the tissue level, it has 
been hypothesized that these differences arise largely from differing quantities of specific 
cell types in any given region, while the individual cells of each type remain analogous in 
function regardless of regional affiliation[5]. Therefore, a layer V pyramidal neuron in 
the sensorimotor cortex may hypothetically perform the same general functions as a layer 
V pyramidal neuron of the medial prefrontal cortex. 
The axons, the projections that send out information integrated by the neuron, 
reach their respective targets around birth (postnatal day 0) and invade them in the days 
immediately after (P0-P5 in the rat)[10]. Axon guidance is a complex process involving 
ligands produced by the surrounding tissues and axonal targets, which bind to receptors 
on axon growth cones and mediate restructuring of the actin cytoskeleton to promote 
either attraction or repulsion[11]. Ephrins are a class of cell surface proteins that can act 
as both attractant and repulsive signals which bind to EPH receptors on the axonal growth 
cone[12]. Netrins are secreted repulsive proteins which bind to UNC receptors on the 
growth cone[13]. Semaphorins can be either secreted or cell surface proteins acting as 
repulsive signals that bind to Plexin receptors[12]. All of these classes of proteins are 
highly conserved throughout the animal kingdom and have been observed in the guidance 
of axons in C. elegans and D. melanogaster, as well as all mammals[11]. 
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The next major step in development for these neurons is synaptogenesis, where 
the synapses that carry information from one neuron to the next are finally formed. This 
stage of development begins at P7 and reaches its peak by P14[14]. This process occurs 
concurrently with dendritogenesis, the process by which the projections form that receive 
information from other cells (dendrites), also reaches peak activity at age P14[15]. 
Neuronal Gene Expression 
It has been particularly difficult to identify the molecular underpinnings of the 
various decision points for cell types in the neocortex[3]. Many labs have focused on 
specific marker proteins for the cell types that they study. These markers are often used 
by only one or a small group of labs, leading to potential confusion about the identities of 
those cell types. To further complicate the issue, current studies have concluded that no 
one marker can positively identify a single cell type, but that signatures of multiple genes 
are needed to identify one cell population from another[16]. Therefore, the 
documentation of new markers is essential to understand the identities and function of 
individual cell types[10,16]. 
Thus, the identification of novel marker genes is currently a primary focus in the 
field, with several groups doing similar work to try to better define the molecular 
identities of each neuron type[17,18,19,20]. Most of these studies are considering many 
different cell types (up to dozens) at once, or even looking at transcription of multiple cell 
types together at the gross tissue level. This study focuses specifically on Type I and II 
layer V pyramidal neurons, which might provide less noise and greater resolution of the 
differences between just the two closely related neurons. 
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Type I neurons are distinct from Type II neurons in their gene expression, 
hodology (connections to other neurons), morphology and electrophysiological 
behavior[1]. The aim of this project is to address the gap in our knowledge of their gene 
expression. Their hodological differences have already been mentioned, Type I neurons 
project their axons subcortically and Type II neurons project contralaterally. They are 
morphologically distinct in that Type I neurons tend to be larger with more densely 
branching apical dendrites that reach up into layer I of the neocortex, while Type II 
neurons tend to be slightly smaller with more sparsely branched apical dendrites[21]. 
Electrophysiologically, Type I neurons display a prominent h-current and bursting 
behavior[21]. That is, after the neurons fire an action potential the membrane voltage can 
display a depolarization, bringing it to the threshold for another action potential, like 
pace-maker cells in the heart (h-current). That causes the neuron to have the tendency to 
rapidly fire another action potential even if the subsequent stimuli are less than the 
previous ones, which can lead to several action potentials following each other in rapid 
succession (bursting). Type II neurons lack the prominent h-current and do not show 
bursting activity[21]. 
Classification of Layer V Neurons 
There are two gold standard methods for positively identifying the two neuron 
types. First, they can be determined electrophysiologically via patch clamp to look for the 
electrical behaviors of each[22]. This is the most reliable method for determining the 
identity of an individual neuron because the differences between the two (h-current and 
bursting) are pronounced. However, the skillset for electrophysiology is difficult to 
master, is relatively expensive and only allows determination of one neuron at a time. 
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The other method involves retrograde labelling of neurons through latex 
microbeads or similar technique[21]. This process involves making an injection of some 
type of labelling compound, such as latex microbeads, into the regions that the axons 
project to. The labelling compound is then picked up by the axons of the target neurons 
and transported back to the soma of the cell. This approach has the advantage of being 
able to label hundreds of cells at once and is less expensive than electrophysiology, but 
still requires technical skills as well as several days of incubation before the cells are 
fully labelled. This method requires very precise control over the location of the injection 
sites to within a few tens of micrometers with the use of stereotaxic equipment to ensure 
the correct brain regions are targeted. Both methods are also relatively uncommon 
laboratory techniques and require expensive specialty equipment so their use is limited to 
relatively few labs. 
The use of immunohistochemistry to look for protein markers has advantages as 
an alternative to these methods because it is less expensive and requires a simpler skill set 
in one of the most common techniques in the modern molecular biology lab. It is a 
shorter methodology than microbead retrograde labelling, and a large number of 
commercial antibodies are available, making this a very flexible and customizable 
technique for labelling cells. One of the biggest advantages, as with microbead labelling, 
is the ability to probe entire tissues at once to find hundreds to thousands of the target 
cells. 
The difficulty comes from the need to use multiple antibodies on each tissue, as 
well as  all of the risks of multiple channel fluorescence immunohistochemistry[23]. The 
antibodies used require careful coordination to ensure that the primary antibodies bind 
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their targets without nonspecific labelling. Each primary antibody was raised in a specific 
organism (e.g. Rat, Rabbit, Mouse) and the secondary antibodies are designed to bind 
specifically to the antibodies of a particular species. Therefore, if multiple primary 
antibodies are being used, only one of each species can be used in any one experiment. 
The secondaries, if used in fluorescence microscopy, will bind to the primary antibody of 
a specific species and will absorb a specific wavelength of light and emit light of a 
different wavelength. The secondary antibodies must also be selected carefully to avoid 
emission spectra that overlap. 
CTIP2 is well established in the literature as a Type I marker protein, and SATB2 
is a well-established Type II marker protein[3,9,16,17]. Both are transcription factors 
associated with axon guidance, CTIP2 is crucial for Type I neurons finding their 
subcortical targets, while SATB2 suppresses CTIP2 expression and guides the axons 
contralaterally[24,25]. However, there is some overlap between the two, so neither can be 
used alone to definitively identify either type. When used in conjunction, a neuron that 
displays high expression of CTIP2 and low expression of SATB2 can be positively 
identified as Type I and a neuron with high expression of SATB2 and no CTIP2 
expression can be positively identified as Type II[17]. Finding new marker proteins 
would add to our ability to identify large quantities of cell types in a given tissue sample. 
As mice age, many of the markers identified in Hypothesis 1 were predicted to 
decrease in expression because many are associated with developmental processes that 
should be ending as the mouse approaches adulthood. For example, Islr2 is one of my 
putative gene markers and it is already associated with axon guidance[26]. Since the 
axons of Type I and Type II neurons are actively developing at age P1 when RNA 
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sequencing was performed, then it makes sense to find expression of this type of gene. 
However, the axons have fully matured by adulthood[24] so genes regulating functional 
maintenance of the neuron, such as those for ion channels, would be expected in higher 
numbers instead. The question as to whether there will be a difference in expression 
between the two regions of the neocortex is an open one. It may be that different regions 
have developmental gene cohorts that are unique to that region but this is a question that 
has not been directly studied extensively. This could provide valuable insight into why 
some mental disorders are associated with specific brain regions.  
Recently, a powerful new approach to this issue, of determining new markers, 
was developed which involves high-throughput neuronal subclass purification to obtain 
population level RNA-sequencing data[17]. In other words, specific cell types are 
isolated by tagging them using known markers and then sorted with flow cytometry. 
RNA is then extracted from the resulting populations of cells, and RNA sequencing 
performed on this material by reverse transcribing the mRNA to make a cDNA library, 
and comparing that library to a reference genome. A reference genome is a previously 
assembled sequence database used as a representative example of the desired species 
genome. Reference genomes, such as Ensembl[27] or the UCSC genome[28], are 
regularly updated to reflect current research including newly discovered genes or 
correcting errors and misunderstandings from previous versions. All work on this project 
used the Ensembl reference genome release 89[27]. 
This technique yields a dataset with many transcripts for each locus in the 
genome, known as deep sequencing, that provides much higher quality for future 
analysis. The dataset is then used to look for genes associated with this molecular 
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program of differentiation. It also allows a new platform to assess whether the existing 
cell types are valid or if subtypes exist within these groups. The gene expression data 
files for this work, which can be found publicly available on the NCBI database, were 
performed by Molyneaux et. al. (2015)[17]. 
In Molyneaux et. al. (2015), the authors examined the expression of three cell 
types in the mouse primary somatosensory cortex at four different ages during 
development E15, E16, E18 and P1[17]. The three cell types included the two cell types 
mentioned of interest in our lab, Type I and Type II pyramidal neurons found in layer V 
of the neocortex, as well as a layer VI corticothalamic neuron type which was not part of 
the focus of this project. Only the data for Type I and II pyramidal neurons from P1 was 
processed for the analysis of this project, as it coincides with the youngest age group for 
our following IHC experiments. 
The Molyneaux et. al. (2015) paper used a method for cell purification that they 
had previously published which has become common practice in the field[3]. In this 
paper specifically, they manually excised the primary somatosensory cortex of a litter of 
mice (6-10 per litter) for each of eight replicates at the appropriate age[17]. The tissue 
was then dissociated into a single-cellular suspension using papain and fixed with 4% 
paraformaldehyde[17]. 
The single cell suspension was then immunostained with anti-CTIP2, anti-SATB2 
and anti-TLE4 antibodies[17]. They used the differential expression of these three marker 
antibodies to identify the three neuron types in their study. Type I neurons were identified 
as having high CTIP2, low SATB2 and low TLE4 expression[17]. Type II neurons were 
identified as having high SATB2, no CTIP2 and no TLE4 expression[17]. Whereas, layer 
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VI pyramidal neurons have high TLE4, moderate CTIP2 and low SATB2 expression[17]. 
In this project, layer VI pyramidal neurons were excluded by cropping only layer V in the 
regions of interest in the images. 
The cells were then sorted via fluorescence activated cell sorting (FACS) based 
on the differential staining for these antibodies between the three neuron types, where 
each sample would be sorted for all three antibodies simultaneously[17]. Using these 
antibodies to label the neurons comes with the caveat that it only labels a subset of each 
neuron type. Therefore, the neurons identified hereafter as Type I neurons are those that 
have high CTIP2, low SATB2 and (in the case of the Molyneaux dataset) low TLE4 
expression[17]. Likewise, the neurons identified hereafter as Type II neurons are those 
showing high SATB2, no CTIP2 and (in the case of the Molyneaux dataset) no TLE4 
expression[17]. 
Using these three transcription factors together provides a reliable way to 
positively discriminate between all three cell types, if admittedly a subset of each, and 
was one of the biggest contributions of the Molyneaux et. al. (2015) paper[17]. Using 
fluorogold injections (a retrograde tracer similar to the microbeads mentioned above) into 
either the pons, contralateral cortex or the thalamus they were able to verify that the 
antibodies were correctly staining the Type I, Type II and layer VI neurons, 
respectively[17]. Also, as the goal of this analysis is to examine the most differentially 
expressed genes between the cell types then any contamination of misidentified cells 
should have a low overall effect on the sample. 
The cell populations that they obtained were high quality with RNA integrity 
numbers (RIN) ranging between 6.4 and 9 (median at 7.1) and obtaining approximately 
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100,000 cells and 200 ng of total RNA per population[17]. This method of cell sorting 
has been reproduced by many labs in the field and has proved a reliable alternative to 
other methods such as retrogradely transported latex microbeads[3]. 
Image Analysis 
Analyzing images that are the result of fluorescence microscopy can be a 
challenge[23,29]. The amount of observed fluorescence is not directly quantifiable in 
most cases but fluorescent intensities can be used for comparative studies[30]. Also, only 
the presence of fluorophore can be measured, not the antigen itself, yet they should be 
proportional. Even in properly controlled experiments there are many variables that can 
have large effects on the level of observed staining; tissue preparation, quality of the 
antibodies, time and temperature of incubation with antibodies[29]. These potential 
pitfalls must be taken into account to mitigate their hazards. 
These issues are compounded when analyzing images with multiple channels of 
staining[31]. Direct comparison between absolute level of fluorescence of fluorophores 
can be a fool’s errand, because one can never be sure that the differential intensities 
reflect the biological reality of the objective amount of antigens. This is the problem at 
the heart of colocalization analysis[31]. 
It is common in the literature for groups to merely show a micrograph with two or 
more fluorophores and declare subjectively whether they are colocalizing[23,31–34]. A 
common approach to aid this process is to selectively color fluorophores so that their 
overlap in images produces a third color that is the additive sum of the two[31]. For 
example, if different fluorophores are colored red and green, then colocalization of the 
two would appear yellow to our eyes. A similar effect can be obtained with magenta and 
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green, which produces white on overlap and has the added benefit of being readily 
discernible even if the viewer is red-green colorblind. This crude method of 
colocalization has the core limitation that large differences in intensity between channels 
can underestimate the amount of observed colocalization as strong fluorescence in one 
channel can effectively wash out the fluorescence of the other if it is sufficiently low[31]. 
Colocalization analysis can be broken down into two separate methods. First, 
pixel-based methods, where the relative intensities of each channel is compared for every 
pixel in the image[32]. This method is often easier to implement and understand 
conceptually, because the output is a combination of correlation coefficients and easily 
interpretable graphs. However, pixel-based methods are more sensitive to noisy images 
and differential staining between fluorophores (such as one that localizes in the nucleus 
and another that localizes in vesicles or the projections). 
The second, object-based methods use object recognition algorithms to find 
objects located in the plane of the image and makes all comparisons based on those 
objects[35]. This is a more recent development and is often more technically difficult to 
implement and understand conceptually because the correlation coefficients and output 
graphs are more complicated to interpret. However, object-based methods offer more 
robust results that are much less sensitive to noise and differential staining patterns. 
In pixel-based methods, the relative intensity of each channel is extracted from 
each pixel and a Pearson’s correlation coefficient along with Mander’s overlap 
coefficients are calculated[32]. Pearson’s correlation results in a coefficient ranging from 
-1 to 1. A coefficient of -1 corresponds to a negative correlation between fluorophores, or 
complete avoidance of the fluorophores. A coefficient of 1 represents a positive 
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correlation or complete colocalization of fluorophores. Mander’s coefficients, otherwise 
known as overlap coefficients, quantify the incidence of one channel overlapping the 
other and are calculated for each channel and range from 0 to 1. Therefore, an image 
yielding the Mander’s coefficients of M1: 0.80 and M2: 0.20, would be interpreted as: 
80% of pixels with    non-zero intensities in channel 1 also have non-zero intensities in 
channel 2 and 20% of pixels with non-zero intensities in channel 2 also have non-zero 
intensities in channel 1. 
The other main output of pixel-based methods is a cytofluorogram, which 
represent colocalization graphically[33]. The intensities of channel 1 are plotted against 
the intensities of channel 2 on a standard scatterplot. Complete colocalization would 
correspond to a solid straight line at 45° (Figure 1, D). Complete colocalization is a case 
where the intensities in both channels are equal for every pixel. Complete avoidance 
would correspond to two solid straight lines following each major axis independently 
(Figure 1, F). Partial colocalization manifests as wide bands, vase shaped structures or 
distinct groupings of data points (Figure 1, E).  
Object-based colocalization methods utilize object finding algorithms similar to 
those used in computer vision software to find objects of interests in an image[36]. Then 
spatial analyses, such as Ripley’s K function, are used to determine colocalization. 
Although this method is more difficult to implement and less commonly used, the results 
are much more robust. These methods do not rely solely on the spatial relationship of the 
location of the objects in the image as opposed to the pixel intensity data so are relatively 
insensitive to noisy images, differences in fluorescence intensities and different staining 
patterns. The user can also set size thresholds so that objects too small or large to be an 
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intended target can be automatically excluded. The main output of this type of analysis is 
a survey of objects that are either colocalized, in channel 1 only or in channel 2 only. The 
output can therefore be represented as a ratio of colocalized to non-colocalized objects. 
 
 
Figure 1: Sample cytofluorograms from pixel-based colocalization methods. (A-C) 
Simulated fluorescence micrographs showing complete colocalization, partial 
colocalization and avoidance. (D-F) The corresponding cytofluorograms for each 
condition. 
Computer Coding and Automation 
This project involved a large amount of coding in various computer languages, 
between the Neuroinformatics, image processing/analysis and statistical analysis. While 
many of the methods utilized here could have been performed by a human, the sheer size 
of datasets and the need for precision and reliability in data acquisition necessitated the 
use of automation in several instances. Luckily, many of the programs available for 
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processing large genetic datasets bear the brunt of this for the Neuroinformatics 
methods[37]. This is not the case for image processing and analysis, especially when 
batch processing several dozen images simultaneously. 
When deciding whether to automate a process it is necessary to weigh the benefits 
and costs of developing your own code. The process of development often requires a 
large amount of streamlining and testing for verification[38]. The verification process 
requires manual analysis on at least a small portion of raw data, to ensure that the code is 
functioning correctly. Depending on how labor intensive the manual methodology is, 
automation may be more labor intensive than manual analysis. However, when 
automation works correctly the results can pay massive dividends. In the case of this 
project the code more than made up for the effort that was saved from manual data 
acquisition. 
Reproducibility in science is another very important consideration[38–41]. For 
example, obtaining the exact same data from manually counting cells in the microscopy 
images would be nearly impossible since displacements in the locations of cells by just a 
few pixels (an almost imperceptible shift to the human observer) may have a statistically 
meaningful effect on the results depending on the situation. The same is true of the 
bioinformatics analysis, there are so many permutations of the way that each analysis can 
be run that it is important to keep a record of each command that is entered to ensure 
reproducibility[37]. 
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CHAPTER II 
NEUROINFORMATICS 
Methods 
Differential Expression 
The dataset that this project is based on was a result of experiments performed by 
the Arlotta lab out of Harvard University[17]. Their tissue was gathered from the primary 
somatosensory cortex (SSp) at prenatal stages of development through postnatal day 1 
(P1)[17]. Analysis of the Molyneaux[17] dataset began with collecting the data files from 
the NCBI database. These files were downloaded to a Linux server (running Ubuntu 
16.04.02 LTS).  
The sequence read files were downloaded from NCBI as SRA files, eight Type I 
neuron files and eight Type II neuron files (SRR1658922, SRR1658923, SRR1658928, 
SRR1658929, SRR1658934, SRR1658935, SRR1658940, SRR1658941; and 
SRR1658920, SRR1658921, SRR1658926, SRR1658927, SRR1658932, SRR1658933, 
SRR1658938, SRR1658939 respectively). The Mus musculus Ensembl build GRCm38 
reference genome and annotation files were downloaded from igenomes 
(ftp://igenome:G3nom3s4u@ftp.illumina.com/Mus_musculus/Ensembl/GRCm38/Mus_
musculus_Ensembl_GRCm38.tar.gz on 5/01/17). The SRA files were converted to fastq 
format with fastqdump (sratoolkit version 2.8.2-1). 
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The tuxedo protocol[37] was followed using the public Galaxy server to perform 
differential gene analysis (UseGalaxy.org version 17.01). Galaxy’s fastq groomer was 
used to prepare the fastq files to make them more amenable to the Galaxy software 
(Galaxy version 1.0.4). The sequences were aligned to the reference genome with 
TopHat2 (Galaxy version 2.1.0), all settings left as default. The aligned transcripts were 
assembled with Cufflinks (Galaxy version 2.2.1.0), all settings left as default, except bias 
correction set to yes. Cuffmerge was used to combine the resulting assemblies together 
into a parsimonious transcriptome (Galaxy version 2.2.1.0), all settings left as default. 
The differential analysis is performed with Cuffdiff (Galaxy version 2.2.1.3), all settings 
left as default, except bias correction set to yes. For my design, it identified over 5000 
differentially expressed genes when comparing Type I and Type II neurons. 
The workflow designed for this analysis was saved for reproducibility and for use 
in future experiments. A graphical representation was downloaded directly from the 
websites user interface (Appendix B). The workflow can also be downloaded as a file and 
loaded into other profiles or instances of Galaxy so other users can follow the exact same 
protocol. The workflow was published in the UseGalaxy.org published workflow section 
(https://usegalaxy.org/u/bioryguy/w/copy-of-moly-redo) and is available via search at the 
website. 
Physiological Relevance 
The output from Cufflinks was then processed with AltAnalyze v2.1.0 
(http://AltAnalyze.org/)[42]. AltAnalyze is a software application designed for analysis 
of alternative splicing-sensitive platforms such as RNA-seq and microarray. Importantly, 
it also allows for the identification of biologically relevant gene clusters. The program 
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can determine, for example, that genes associated with axon guidance are elevated in a 
target population, as they are in these two cell populations. These GO-Elite[43] pathways 
are useful for developing an idea of clusters of differentially expressed genes and gives 
some insight into how they may be interacting with each other. 
AltAnalyze also outputs some useful analyses for quality control such as lineage 
profiling analysis. Lineage profiling produces both tissue fate maps for each of the 
selected cell types (in this case one each for Type I and Type II), and a heat map 
visualization with hierarchical clustering. The tissue fate maps provide an idea of which 
types of tissues are most similar to your experimental groups and highlights those groups 
on a tissue lineage network map[42]. The heat map visualization provides a hierarchical 
clustered list of tissue types that are most and least similar to each of your experimental 
groups. 
AltAnalyze was set to process RNA-seq aligned read counts from junction BED 
files with a moderated t-test and using default parameters. The same Ensembl database 
(Mus musculus Ensembl build GRCm38) was downloaded through the AltAnalyze user 
interface to match the reference database for the Cufflinks dataset. Options to predict 
biomarkers, perform lineage profiling and to analyze ontologies and pathways with GO-
Elite were selected to run. ASPIRE was left as the default alternative exon finding 
algorithm. 
The output of AltAnalyze was also loaded into Excel to identify targets for 
Hypothesis 2. Approximately 5000 differentially expressed genes were analyzed to try to 
determine good candidates for cell type specific markers. Since AltAnalyze performs its 
own statistical analyses of the differential expression patterns, all of the genes with a 
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p-value greater than 0.05 were removed as non-significant. The remaining genes were 
then sorted by the level of differential expression, as the genes with the highest difference 
in expression were the most likely to be cell type specific markers.  
Gene expression levels are presented in units of FPKM (Fragments per kilobase 
of transcript per million mapped reads), and the differential expression is often quantified 
as a base 2 logarithm. The level of expression varies in the database from a maximum of 
6,292 FPKM to a minimum of 0.03851 FPKM with a median of 15.25 FPKM. The genes 
identified were chosen as candidate markers because they were all above the median 
expression (15 FPKM), in at least one of the cell types, and with a differential expression 
of log2(<4) which corresponds to a minimum 16-fold difference. These criteria were 
chosen because they provided a reasonable size to the list of candidate genes (fourteen); 
for example, using a lower differential expression threshold of log2(3) yielded a candidate 
list of 294 genes. 
Genes with a low overall expression level (<15 FPKM) would be avoided even if 
they were highly different in expression levels. The rationale behind this is that even if 
two genes have approximately the same relative differential expression, the gene with 
higher absolute levels of expression is a better candidate from the standpoint of easier 
identification with immunohistochemistry. In other words, if there are higher levels of 
protein expression then there are more target epitopes for antibodies. It was assumed that 
mRNA expression levels correlate positively with protein expression levels, however it is 
worth noting that this is not necessarily the case. 
For verification of the results from AltAnalyze, the output of Cufflinks was also 
processed in the Database for Annotation, Visualization and Integrated Discovery 
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(DAVID v6.8; https://david.ncifcrf.gov/), which performs similar functions of 
determining biological relevance of genes[44]. Domain Graph v3.01 was used to 
visualize biologically relevant gene clusters[42]. 
Results 
 Fourteen genes in our dataset met the above criteria (statistically significant 
differential expression, differential expression > log2(4), and overall expression > 15 
FPKM), seven Type I and seven Type II putative gene markers (Table 1 and Table 2 
respectively). Note that one of the most differentially expressed genes in the dataset is 
Ctip2, the established Type I marker. Satb2, the established Type II marker, is also in the 
dataset and narrowly missed the short list. All the putative type markers were also 
identified as predicted biomarkers by AltAnalyze. 
Table 1: Putative Type I marker genes 
Gene ID 
Diff. Expression 
(log2) 
Type I Expression 
(FPKM) 
Type II Expression 
(FPKM) 
Crym 6.91 48.6 0.404 
Tcerg1l 6.23 90.5 1.21 
Npr3 5.83 15.6 0.256 
Kif26a 5.74 136 2.53 
Ctip2 5.66 117 2.31 
Islr2 4.22 448 24.0 
Pcp4 4.92 57.4 1.90 
Table 2: Putative Type II marker genes 
Gene ID 
Diff. Expression 
(log2) 
Type I Expression 
(FPKM) 
Type II Expression 
(FPKM) 
Inhba -6.27 0.235 18.1 
Fn1 -5.94 0.908 55.8 
Cux2 -5.34 2.61 105.6 
Plxna4 -4.64 2.74 68.6 
Lhx2 -4.37 7.26 151 
Shisa2 -4.36 1.01 20.8 
Ntng2 -4.08 13.4 227 
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A literature search reveals some very important points about these genes of 
interest. First, is that most of these genes are so far unassociated with the neurons that are 
the subject of this study. Some are associated with these neuron types in other ages or 
brain regions, but only Ctip2 has ever been observed before in both these ages (P1, P7) 
and brain regions (mPFC, SSp)[3]. Second, is that several of them are associated with 
physiological processes that are known to be active in these neurons at this stage of 
development, such as axonal guidance (notably Islr2, Plxna4 and Ntng2)[13,26,45]. 
Third, is that several of these genes are known to be transcription factors (Crym, Tcerg1l, 
Ctip2 and Lhx2)[3,46–48], which are important because they will then drive the 
expression of other genes downstream, i.e. constituting gene networks that may control 
global expression of layer V appropriate properties. Likewise, Cux2 contains a homeobox 
DNA binding domain, so it may be a transcription factor as well[49]. Fourth, the 
physiological roles of these genes are unknown for almost all of these genes in the 
neurons of interest of this study, so until functional studies are performed on each gene 
individually their roles are speculative. Last, is that several of these genes are also 
associated, via genome-wide association studies, with neurological disorders. Some of 
these disorders are also associated with either Layer V pyramidal neurons or the medial 
prefrontal cortex; such as ADHD (Tcerg1l)[50], Autism (Pcp4)[51], Epilepsy and 
Schizophrenia (Fn1)[52,53] or Parkinson’s disease (Plxna4)[45]. This might have clinical 
significance as these genes or their proteins may be viable targets for treatment in these 
disorders. 
23 
 
  
The following summarizes the significance of each of these genes within the 
literature. Mu-crystallin (Crym, or NADP-regulated Thyroid-hormone-binding protein) is 
a transcription factor with a direct role in gene transactivation mediated by the thyroid 
hormone T3 [54]. More importantly, this gene is already associated with neuronal 
differentiation in Layer 5 pyramidal neurons of the primary somatosensory cortex[3]. 
This gene has the highest differential expression of the markers for Type I neurons in this 
analysis. 
Recent studies show that Transcription elongation regulator 1-like (Tcerg1l) is 
expressed in Type I neurons of the primary visual cortex of adult mice[55]. Expression is 
also increased in gross tissue sections of the macaque prefrontal cortex[47]. Tcerg1l is 
also associated with ADHD in human patients[50]. 
There is little relevant information in the literature for Natriuretic peptide 
receptor 3 (Npr3), but it has recently been associated with axonal branching in dorsal 
root ganglion neurons of the mouse spinal cord[56]. Kinesin family member 26A (Kif26a) 
encodes an atypical kinesin that is associated with enteric neuronal development[57]. 
 Of all the putative markers identified here, Coup-TF-interacting protein 2 
(CTIP2, or Bcl11b), is the only one with a well-documented role in the development of 
Type I or II neurons in the literature. It is one of the best known markers of Type I 
neurons[3]. Ctip2 acts to guide the axons of Type I neurons to targets outside of the 
neocortex, such as the brain stem[10]. Knockouts of this gene spontaneously abort just 
before birth, and completely lack Layer V neurons with corticofugal axons[58]. 
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 Immunoglobulin superfamily containing leucine-rich repeat 2 (Islr2) is required 
for axon extension at the optic chiasm during neural development of retinal ganglion cells 
in vertebrates[26]. Islr2 is the most highly expressed transcript in Type I neurons. 
 Purkinje cell protein 4 (Pcp4) codes for a small calmodulin binding protein, and 
is highly expressed in Type I neurons. Pcp4 is documented in corticospinal motor 
neurons of the sensorimotor cortex and visual cortex of the mouse[3] and its altered 
expression in the dorsolateral prefrontal cortex is associated with autism in human 
patients[51]. 
 Inhibin beta A (Inhba) is expressed in Type II neurons of the adult mouse 
somatosensory cortex[59]. This gene is the most differentially expressed Type II marker 
in our analysis, but has a moderate overall expression level. Fibronectin 1 (Fn1), codes 
for a cell adhesion extracellular matrix protein, is involved in the development of 
tecto-thalamic projection neurons in the tectum (a structure in the mid-brain that 
processes auditory and visual reflexes) of the rat[60]. It is also associated with both 
epilepsy and schizophrenia in humans[52,53]. 
Cut-like homeobox 2 (Cux2), like Inhba, is expressed in Type II neurons of the 
adult mouse somatosensory cortex[59]. However, at later ages Cux2 is more highly 
expressed in more superficial layer neurons (layer 2/3 and layer 4) and is speculated to be 
a transcription factor[55]. These lines of evidence suggest that the expression of this gene 
varies widely within cell types over maturation of the animal. 
 Plexins are a class of membrane receptors for semaphorins and are well known in 
directing neuronal dendrites and axons[59] as is Plexin A4 (Plxna4). The PLXNA4 
protein specifically acts by inducing axonal growth cone collapse upon binding with the 
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semaphorin, SEMA3A[61]. This gene is also associated with Parkinson’s disease in 
humans[45]. LIM/homeobox 2 (Lhx2) is expressed in Type II neurons postnatally in the 
mouse primary somatosensory cortex[62]. 
 There is also little in the literature about Shisa homolog 2 (Shisa2) involving mice 
or even mammals. It is an inhibitor of WNT and FGF signaling pathways in Xenopus, 
and appears to be enriched in murine in vitro embryonic stem cell cultures lacking 
retinoic acid, which is itself associated with neural differentiation[63]. 
By contrast, there is much more information about Netrin G2 (Ntng2). The Netrin 
family of proteins is a large protein family that is generally associated with outgrowth of 
neuronal projections[64]. Ntng2 is involved in controlling neuronal projection patterning 
within specific lamina[13] and regulates synapse development[65] in the mouse 
hippocampus. Its expression has also been observed in Type II neurons of the mouse 
primary somatosensory cortex, like some of the other genes on this list[17]. This gene 
also had the highest expression of all the putative Type II cell markers in this analysis. 
The lineage profiling analysis and GO-Elite pathway analysis both produced 
similar results. Associations with neural development were identified with both 
methodologies. The lineage profiling identified closely related tissues for both cell types 
such as brain and fetal spinal cord. The highest correlation was seen with neural 
progenitors and visual cortex. Interestingly, neither prefrontal cortex nor somatosensory 
cortex were highlighted. 
Ontology analysis showed that the two cell types are indeed very similar in the 
types of genes expressed as evidenced by the similarities in Z-scores. Both cell types 
were most highly correlated with cell types associated with neurons, development or both 
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(fetal spinal cord, visual cortex, neural progenitor, neurons, dopaminergic progenitor, 
brain). Interestingly, they also expressed genes associated with the endoderm (endoderm 
and endoderm progenitor), even though they are derived from the ectoderm, as well as 
other seemingly dissimilar cell types such as bone type cells (megakaryocytes, bone 
marrow hematopoietic cells, erythroblast progenitors) and cardiac tissue (early and late 
cardiac progenitors, cardiac progenitors). Finally, where they differ offers some 
interesting comparisons. For example, Type II neurons showed slightly positive 
associations for Cardiac fibroblast progenitors as well as Thymus cells and Endoderm 
progenitors where Type I neurons showed negative associations for those tissues. 
The results of the lineage profiling analysis and GO-elite pathway analysis, 
perhaps more than anything, verify the reliability of the rest of the output from 
AltAnalyze. If there were very unusual results coming from these lines of evidence it 
would suggest problems with the reliability of the results, but for the most part these 
results are as expected, the neurons resemble the tissue that they derive from and are very 
similar to each other with notable exceptions. 
Looking at the network diagrams can help highlight why some of these other cell 
types are resulting from the lineage profiling and ontology analysis. Both Ctip2 and Satb2 
were present in the Regulated Gene Network as were the putative type markers, Ctip2 
(Bcl11b), Satb2, Inhba and Lhx2 (Figure 2). Many genes up-regulated in Type I neurons 
were associated with the Nervous system or Neurological phenotype (Figure 3). Several 
of the Type I putative markers were also reflected in this network (Ctip2, Crym, Islr2, 
Pcp4 and Kif26a). 
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Figure 2: Regulated gene network. Blue gene nodes are associated with Type I neurons; 
red gene nodes are associated with Type II neurons. Lines between nodes indicate 
positive association in the literature. Arrows between nodes represent positive regulation 
on the target of the arrow. Highlighted genes are those identified as genes of interest in 
this study; Green = Ctip2 (Bcl11b) and Satb2, yellow are putative markers. 
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Figure 3: Genes up-regulated in Type I neurons. The two square nodes in the center 
represent gene ontology phenotypes, nervous system and behavior/neurological 
phenotypes are present here. The arrows pointing from each gene node indicate active 
regulation of the arrows target. Highlighted genes are those identified as my genes of 
interest; Green = Ctip2 (Bcl11b), yellow are putative markers. Pcp4 and Islr2 are 
associated with both phenotypes.  
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Figure 4: Genes up-regulated in Type II neurons. The two square nodes in the center of 
each cluster represent gene ontology phenotypes, transcription regulator and receptor 
phenotypes are present here. The arrows pointing from each gene node indicate active 
regulation of the arrows target. Highlighted genes are those identified as my genes of 
interest; Green = Satb2, yellow are putative markers. 
Many of the genes up-regulated in Type II neurons were associated with 
Transcription regulation (Figure 4) as well as receptors, including Eph receptors which 
are involved in axon guidance of the developing neuron. Likewise, many of the Type II 
putative markers were in this network (Satb2, Lhx2 and Cux2). Nr4a2 is associated with 
both phenotypes. Several of the receptors are Eph receptors (Epha3, Epha4 and Ephb6), a 
class of receptors known to be involved in axon guidance of developing neurons.  
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Figure 5: CTDOntology Disease phenotypes associated with each neuron type. Blue gene 
nodes are associated with Type I neurons; red gene nodes are associated with Type II 
neurons. The square nodes represent various disease phenotypes, several of which 
produce neocortical function disabilities (Schizophrenia, Autism and Brain Ischemia). 
The arrows pointing from each gene node indicate active regulation of the arrows target. 
The highlighted gene (Cav1) is one of those identified as a gene of interest. 
The Comparative toxicogenomics database (CTD) is an annotated database of 
disease phenotypes and interactions between chemicals, gene products and their 
relationship to those disease phenotypes[66]. The CTD ontology network (Figure 5) 
displays some of the disease phenotypes associated with the differentially expressed 
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genes in this analysis. Schizophrenia and Autism are neurodevelopmental 
disorders[67,51] so it is no surprise to see them in the network. 
Gene clusters associated with axon guidance, a defining characteristic between 
the two cell types, were present in both the up-regulated and down-regulated gene 
networks. Another interesting result is the lack of some of the genes of interest (Tcerg1l, 
Shisa2 and Ntng2) from the network diagrams. The networks represent those gene 
interactions that are documented in the literature[42], so the lack of some putative 
markers may be highlighting what little is known about those genes that are absent from 
the diagrams. That also affords an opportunity for future research into the function and 
interaction of these genes. 
Table 3: Top ten gene ontology terms. Results from GO-Elite analysis sorted by Z-score. 
Ontology Name  
(Ontology-ID) 
Changed Ontology Changed 
(%) 
Z-Score Fisher 
Exact-P 
1. Negative regulation of axon regeneration 4 5 80 11.1 1.90E-06 
2. Neuron projection (GO:0043005) 54 557 9.69 11.0 1.51E-17 
3. Developmental process (GO:0032502) 176 3463 5.08 10.6 9.96E-22 
4. Regulation of cell projection size 
(GO:0032536) 
4 6 66.7 10.1 5.57E-06 
5. Protein binding (GO:0005515) 354 9544 3.71 9.97 4.17E-23 
6. Extracellular matrix (GO:0031012) 36 338 10.7 9.67 2.74E-13 
7. Neuronal cell body (GO:0043025) 35 323 10.8 9.66 3.56E-13 
8. Synapse (GO:0045202) 37 365 10.1 9.42 5.79E-13 
9. FACIT collagen (GO:0005593) 3 4 75 9.29 6.10E-05 
10. Cell adhesion (GO:0007155) 52 637 8.16 9.29 7.11E-14 
In general, AltAnalyze showed an increase in gene networks associated with 
Neuronal differentiation and development. GO-Elite analysis yielded 70 statistically 
significant gene ontology terms (Table 3, top ten). Several gene terms associated with 
development and neurons were present in the top ten alone. Of particular importance is 
that four of the top ten terms (1, 2, 4 and 8) are associated specifically with projections of 
the cell types which is consistent with the gene networks. DAVID functional annotation 
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clustering with the top 100 most differentially expressed genes yielded similar results 
with many gene clusters related to Neural development, Neurogenesis, Cell proliferation 
and Regulation of transcription. 
Fourteen putative type markers were identified by this analysis, many of which 
are undocumented in the literature in these neurons, brain regions and ages. Furthermore, 
the functional relevancy of the genes and gene clusters identified are indicative of the 
physiological, morphological and hodological differences seen between type I and II 
neurons. The targeting of the axons of these neurons is the defining feature between the 
two types and every line of evidence shows that genes associated with these processes are 
differentially regulated. Bringing these genomic techniques into the lab allows the use of 
these same methods on older mice, up to adulthood, in the future to better understand the 
maturation of these neurons.  
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CHAPTER III 
COLOCALIZATION ANALYSIS 
Methods 
Fluorescence Immunohistochemistry 
After the identification of targets from Research question 1, antibodies for the 
corresponding protein products were purchased to characterize protein expression with 
fluorescence immunohistochemistry. The genes identified were based on data from the 
primary somatosensory cortex of a mouse at postnatal day 1 (P1), however the antibodies 
were used to determine the expression of these proteins in the medial prefrontal cortex in 
addition to the primary somatosensory cortex in mice at ages P1 and P7. The decision to 
extend this experiments out to age P7 is part of future plans to extend the genomic 
analysis described in the previous chapter out to adulthood in the mouse, as many of the 
work up to know involves predominantly prenatal mice ages. 
All procedures used throughout this research project were in accordance with the 
University of Northern Colorado Institutional Animal Care and Use Committee protocol 
1606D-MT-M-19 (Appendix A). C57bl/6 mice of both sexes were used in this research. 
All animals were housed 2-4 animals per cage with a 12:12 light/dark cycle, on-site at the 
University animal facility and were provided ad libitum access to food and water. 
All animals were rendered deeply unconscious with CO2 asphyxiation then 
sacrificed by rapid decapitation. The brain was immediately removed, followed by 
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cleansing washes in 1X phosphate buffered saline (PBS) and overnight fixation in 4% 
paraformaldehyde (PFA) at 4°C. Some tissue samples were fixed in 95% ethanol, if 
previous paraformaldehyde fixed experiments yielded negative results. However, ethanol 
fixation did not result in successful experiments in any of these tissue samples. The brain 
was then submerged for two to three days in 20% sucrose at 4°C as a cryoprotectant for 
snap freezing on liquid nitrogen with 2-methylbutane as a freezing medium. The tissue 
was stored in a -80°C freezer until cryosectioning. 
Coordinates for the two regions of interest were obtained from a Developmental 
mouse brain reference atlas for both ages[68]. Tissue for the medial prefrontal cortex 
(mPFC) at age P1 was collected 500-800 µm posterior to the rostral tip of the cerebral 
hemispheres; primary somatosensory cortex (SSp) was collected 1000-1300 µm posterior 
to the rostral tip. At age P7 medial prefrontal coordinates were 500-1000 µm, and 
primary somatosensory cortex coordinates were 1000-1800 µm. Coronal sections at 30 
µm in thickness were obtained on a cryostat at -15°C cabinet temperature, -10°C for the 
specimen holder. The tissue sections were thaw-mounted[69] on a cleaned and poly-D-
lysine coated[70] microscope slide with 10 to 12 tissue samples per slide. The slides were 
left on a slide warmer at 37°C for 30 minutes to aid in tissue adhesion to the slide. 
Primary and secondary antibodies were diluted in 0.2% Triton x100 in phosphate 
buffered saline (PBS). The sections were washed three times in PBS for 20 minutes at 
room temperature then submerged overnight in the primary antibodies in appropriate 
concentration (Table 4). The primary antibodies were then removed and replaced with 
secondary antibodies matched to the type of primaries for one to two hours. Removal of 
the secondary antibodies were followed by three rinses in PBS for 20 minutes at room 
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temperature, followed by nuclear counterstaining with Hoechst 33342, which generally 
stains adenine-thymine rich sequences of the minor groove of double stranded DNA[71], 
for 5 minutes at room temperature. Then a last rinse in PBS for 20 minutes at room 
temperature. 
Primary antibodies were selected carefully to avoid using antibodies raised in the 
same species for colocalization experiments. Some antibodies came with a manufacturers 
recommendation for heat mediated epitope retrieval. For those antibodies, the tissue was 
submerged in a Sodium Citrate buffer solution (10mM Sodium Citrate, 0.05% Tween 20, 
pH 6.0) for 40 minutes at 95°C. Secondary antibodies were carefully selected in these 
experiments to avoid overlap of absorption/emission spectra of conjugated fluorophores.  
After this process, the success of the experiment was confirmed on an inverted 
fluorescent microscope and the sections were permanently mounted with 50% sucrose in 
PBS and the coverslip adhered with clear nail polish. 
The staining of four novel putative markers of each neuron type were assessed for 
a total of eight proteins. Many (6) of the putative marker antibodies showed no staining in 
the target tissue whatsoever, despite best efforts at optimization or epitope retrieval. 
Methods of optimization included variation in concentration, time and temperature of 
incubation, different primary and secondary combinations, tissue preparation and fixation 
methods, and both temperature and enzyme mediated epitope retrieval. The ramifications 
of these failed experiments are explored in depth in the conclusions chapter, but they 
were not used for the final round of experiments. Only PCP4 and TCERG1L (both Type I 
markers) showed positive staining patterns, and TCERG1L only weakly after epitope 
retrieval. 
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Table 4: Antibodies list 
Antigen Species Type HIER Dilutions 
    1°Ab AFgM AFgRb Cy5R 
CTIP2 R IgG2a mAb No 1:250   1:100 
SATB2 M IgG1 mAb No 1:100 1:200   
PCP4 Rb IgG pAb No 1:100  1:200  
TCERG1L Rb IgG pAb Yes 1:10  1:200  
CRYM Rb IgG pAb No 1:250  1:200  
CRYM M IgG1 mAb No 1:200 1:200   
MDGA1 Rb IgG pAb Yes 1:250  1:200  
INHBA Rb IgG pAb Yes 1:100  1:200  
NTNG2 M IgG2b mAb No 1:200 1:200   
CUX2 Rb IgG pAb No 1:200  1:200  
Abbreviations: AFgM, Alexa Fluor goat anti-mouse secondary antibody; AFgRb, Alexa 
Fluor goat anti-rabbit secondary antibody; Cy5R, Cy5 goat anti-rat secondary antibody; 
HIER, Heat induced epitope retrieval; IgG, immunoglobulin G; M, mouse; mAb, 
monoclonal antibody; pAb, polyclonal antibody; 1°Ab, primary antibody; R, rat; Rb, 
rabbit; Species, host species. All primary antibodies were purchased from Abcam, Alexa 
Fluor secondary antibodies were purchased from Molecular Probes, Cy5 secondary was 
received from Dr. Judith L. Leatherman. 
CTIP2 is well established in the literature as a Type I marker, and SATB2 is a 
well-established Type II marker[3,9,16,17]. The RNA-seq dataset used CTIP2 and 
SATB2 to determine cell type[17] so we maintain consistency in neuronal identification 
between our study and theirs. Therefore, the combination of a high level of CTIP2 with a 
low to moderate level of SATB2 staining can be used as a positive identification of Type 
I neurons, whereas high levels of SATB2 staining and negative to low levels of CTIP2 
staining can be used as positive identification of Type II neurons[17]. Their establishment 
in the literature as markers also makes them uniquely suited for use as positive controls. 
Co-staining with these established markers was crucial to the proper identification of 
neuron type in these mice where other methods such as retrograde labelling was not 
feasible at these ages in our lab until recently. Due to the potential simultaneous use of 
CTIP2 and SATB2 antibodies with another putative marker, the antibodies were carefully 
selected for host species to avoid overlap of secondary binding. 
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A final round of four-channel fluorescent photomicrographs was obtained on a 
Zeiss LSM 700 confocal microscope for image analysis. Four-channel experiments were 
important to provide a better basis for comparison between the putative type marker 
(PCP4 or TCERG1L) and both established type markers (CTIP2 and SATB2) in the same 
tissue sample, in addition to the Hoechst DNA stain to show nuclear positions. In order to 
obtain subcellular image resolution but still retain the ability to observe the entire region 
of interest, tile scan images were obtained with image stitching performed by the onboard 
proprietary Zeiss Zen software package. Each tile scan image consisted of seven rows 
and five columns of stitched images taken with bidirectional scanning. All images were 
obtained with a 40x C-Apochromat, 1.2 NA, water immersion lens. Digital images were 
captured with a resolution of 1024 x 1024 pixels, 1.27 µsec pixel dwell time, averaging 
set at 2 and 12-bit color depth. The pinhole diameter for each channel was set to 0.99 
Airy units for image capture. 
Image Analysis 
The images were processed in FIJI v.1.51[72], a distribution of ImageJ, and        
Icy v1.8.6.0[40] to determine the extent of colocalization in the target tissue. Both are 
open-source photo analysis programs. Since there were a large number (n = 87) of final 
images, each with dozens to hundreds of individual cells to be counted and individually 
assessed for colocalization, custom scripts and macros were used extensively to aid in 
automation. Although this resulted in a large investment of time and effort in 
development and optimization of custom code (Appendices C-H), it drastically decreased 
the final processing time. 
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The image analysis was performed largely in four separate steps: image 
correction, pixel-based colocalization, object-based colocalization and statistical analysis. 
Part of the first step, as well as the second and third steps in their entirety, were coupled 
together with a custom script that uses human-in-the-loop principles to utilize the 
strengths of both users and computers (Appendix C). Automated methods were verified 
for accuracy via comparison with manual cell counts on 32 of the final 87 images. 
Another benefit of this investment is greater reproducibility as well as a decrease in 
human bias and error. 
Image correction. To aid in visualization, each four-channel image was split into 
three separate three-channel images using a custom protocol in the Icy graphical 
programming plugin Protocols (Appendix D). All three images have the Hoechst channel 
to help outline the tissue histology. One resulting image has the CTIP2 and SATB2 
channels for use as a control. One compares the CTIP2 channel in addition to the putative 
marker (PCP4 or TCERG1L) for that experiment, denoted as the Type I experimental 
group. The last image compares SATB2 in addition to the same putative type marker, 
denoted as the Type II experimental group. 
Colocalization analysis is very sensitive to static and background staining[23,34]. 
This was particularly true with TCERG1L as there was low overall positive staining and 
a moderate amount of background (i.e. poor signal to noise ratio). One common way of 
minimizing this problem is by thresholding each channel[23]. In this case, the images 
were cleaned up with a modification of a complex masking threshold procedure found in 
the documentation for ImageJ (http://imagej.net/Image_Intensity_Processing). A script 
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automating the process was written as well as another making it suitable for batch 
processing of files (Appendix E). 
Pixel-based colocalization. In Pixel-based colocalization analysis the relative 
intensities of each channel are extracted from each pixel for statistical comparison. 
Pixel-based colocalization was performed both with a custom written script (Appendix F) 
and with the Just Another Colocalization Plugin (JACoP)[23] for FIJI. The custom script 
extracts the intensity data from each pixel and places it in a dataset which allows the 
construction of fluorograms to assess colocalization. Since JACoP is professionally 
developed, it has a large amount of powerful features as well as a strong following in the 
literature[31,34,35]. Pearson’s and Manders’ coefficients were selected to be displayed in 
the log file so that they could be automatically retrieved later with a batch script. 
Object-based colocalization. Object-based methods utilize basic object finding 
algorithms to identify cells (or other objects of interest) within the image then uses spatial 
analysis to determine colocalization[30,36]. Object-based methods were used both for 
comparison to the pixel-based methodology but also because it often provides more 
robust results that are less sensitive to noise, differing staining patterns or brightness 
between comparison channels[36]. The minimum allowed object size was 500 pixels and 
the maximum was 8000 pixels which helped to reduce the influence of artefactual 
staining of extracellular structures and blood vessels. Defaults were used for all other 
settings. 
Manual cell counts were performed on 37% (32 of 87) of the images for 
verification of the automated cell counts obtained from the object-based analysis. Manual 
counts were performed by one expert researcher with the use of manual counting aids in 
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Icy[40]. Coordinate location and number of detections was saved as sequence 
information for each image. Automated cell counts were obtained from the output of 
JACoP. 
Statistical analysis. All statistical analyses and data manipulation were run in 
RStudio v0.99.902. A custom data management script was written to extract the data 
from the text output log files of the Colocalization protocol and compiles the dataset in a 
csv file. A Fisher’s exact test was run for each image individually and a Pearson’s Chi-
squared goodness-of-fit test was used to determine whether there was a significant 
difference overall between the manual and automated cell counts (Appendix G). Once the 
automated cell counts were verified statistically they were compiled into a master dataset 
for all subsequent analyses (Appendix H). 
Multiple linear regression with stepwise variable elimination was used to create a 
model for each putative type marker (one for PCP4 and one for TCERG1L) which took 
age, brain region (mPFC vs. SSp) and marker type as independent variables and 
colocalized proportion as the dependent variable. An ANOVA test was then run on the 
linear model and a Tukey HSD post-hoc test performed pairwise comparisons. Power 
analysis was run to help determine an appropriate sample size of images needed to 
properly detect the expected effect size for a given level of confidence. Two age groups 
and two brain regions left a total of four groups per experiment. I used standard 
significance level (α=0.05), power (1-β=0.8) and effect size estimates (Cohen’s d=0.40).  
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Results 
Fluorescence Immunohistochemistry 
 Of the antibodies purchased for the putative type markers, only PCP4 and 
TCERG1L showed positive staining patterns in IHC experiments. Those antibodies were 
then used for subsequent four-channel experiments with both CTIP2, SATB2 and 
Hoechst stain. Photomicrographs for both PCP4 and TCERG1L were taken for both brain 
regions of interest (mPFC and SSp) and both ages of interest (P1 and P7). 
Both of the putative markers were predicted to be Type I markers so they were 
expected to colocalize more with CTIP2 than SATB2. Furthermore, because the dataset 
was collected from P1 mice in the primary somatosensory cortex; it was expected that 
they would colocalize most in the primary somatosensory cortex at age P1 and less so in 
the medial prefrontal cortex and less in general at age P7. Indeed, the imaging for PCP4 
(Figure 6) supports that first prediction at both age groups, PCP4 clearly colocalizes with 
CTIP2 much more often than SATB2. However, it was not visually obvious that 
colocalization is higher in the P1 mouse than the P7 mouse; or in the primary 
somatosensory cortex over the medial prefrontal cortex. Ultimately the difference 
between brain regions and age groups were not statistically significant. 
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Figure 6: Colocalization of CTIP2 and SATB2 with PCP4. Neurons that are strongly colocalized will appear more white with this 
colorization scheme. (A, D, G, J) CTIP2, a Type I marker, and SATB2, a Type II marker, show that the neuron populations are mostly 
isolated in their expression of these markers. However, there is some overlap. (B, E, H, K) CTIP2 and PCP4 were predicted to have a 
high level of colocalization with the highest expected in pane H. (C, F, I, L) SATB2 and PCP4 were predicted to have a low level of 
colocalization. Overall staining patterns were much as expected. 
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Figure 7: Colocalization of CTIP2 and SATB2 with TCERG1L. Neurons that are strongly colocalized will appear more white with this 
colorization scheme. (A, D, G, J) CTIP2, a Type I marker, and SATB2, a Type II marker, show that the neuron populations are mostly 
isolated in their expression of these markers. However, there is some overlap. (B, E, H, K) CTIP2 and TCERG1L were predicted to 
have a high level of colocalization with the highest expected in pane H. (C, F, I, L) SATB2 and TCERG1L were predicted to have a 
low level of colocalization. Overall staining patterns did not match predictions well.
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TCERG1L was predicted to have similar staining patterns to CTIP2 and PCP4, 
however the imaging does not support that hypothesis (Figure 7). Overall staining with 
TCERG1L was low, which contributed to a large amount of background artifact. No 
discernible positive staining was observed in the medial prefrontal cortex at age P1. 
However positive staining was observed in the primary somatosensory cortex at P1 and 
in both regions at age P7. This suggests temporal differences in the development of these 
two regions. The neurons that are TCERG1L+ are not reliably CTIP2+ or SATB2+ in 
either age group or tissue type (Figure 7, A-L). 
The different patterns of staining are also important to mention. CTIP2 and 
SATB2 are known to be transcription factors and to bind in the nucleus of the cell, CTIP2 
binds the DNA directly and SATB2 binds to CTIP2 acting as a repressor[16]. The 
nuclear staining patterns of CTIP2 and SATB2 is exactly what is seen here. TCERG1L 
also appeared to have a nuclear staining pattern, but the staining pattern of PCP4 seems to 
outline the soma of the neuron in a perinuclear pattern and even reaching down into the 
base of the axon (Figure 6). This difference in staining patterns between CTIP2 and PCP4 
is more pronounced by age P7 (Figure 6; E, F, K and L). This is important because the 
success of pixel-based colocalization methods require very close overlap as well as 
similar staining patterns to be effective. Even though the two proteins are clearly 
occurring in the same neurons, the pixel data will not show that colocalization because 
they are physically sequestered within separate cellular compartments. 
Image Analysis 
Pixel-based methods were not diagnostic. The results for the pixel-based 
analysis were not informative in this case and display some of the limitations of the 
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method (sensitivity to noise and different staining patterns). The fluorograms for both 
PCP4 and TCERG1L experiments show no clear difference between any of the 
experimental groups (Figure 8 and Figure 9). These results do not reflect the images 
obtained for PCP4, where there are clear visual differences between groups. Perfect 
colocalization would show a solid yellow line corresponding to x=y, which is similar to 
the trend that would be expected for the CTIP2/PCP4 comparison (Figure 8, B and H). In 
the case of avoidance, a complete lack of colocalization, the fluorograms would have two 
separate lines settled along the vertical and horizontal axes, expected in the 
CTIP2/SATB2 and SATB2/PCP4 comparisons (Figure 8; A, C, G and I). Instead of 
either of those states most of the fluorograms display fan shaped structures without much 
difference between groups that should display very different structures. The images for 
TCERG1L did not show any obvious or reliable colocalization anywhere. So the fan 
shapes displayed in the fluorograms (Figure 9) are consistent with the photomicrographs 
(Figure 7), however, this does not agree with the prediction, from Hypothesis 2, that 
TCERG1L would colocalize with CTIP2. 
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Figure 8: Fluorograms for PCP4 experimental groups. Perfect colocalization would show a solid yellow line with a slope of 1. 
Avoidance would be two separate lines falling roughly along the horizontal and vertical axes. These fluorograms do not indicate any 
consistent relationships between groups, which does not appear to reflect the relationships observed in the photomicrographs. 
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Figure 9: Fluorograms for TCERG1L experimental groups. Perfect colocalization would show a solid yellow line with a slope of 1. 
Avoidance would be two separate lines falling roughly along the horizontal and vertical axes. These fluorograms do not indicate any 
consistent relationships between groups.
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One concern is that the Pixel Intensities script (Appendix F) might not extract 
valid data from the images. However, the JACoP plugin also produces a dataset that can 
be analyzed by the same code to create a fluorogram for comparison between the two. 
The corresponding fluorogram pairs are visually identical (Figure 10). 
 
Figure 10: Pixel intensities code compared to JACoP. The output of the custom written 
code (A, B, C) compared to the output of JACoP (D, E, F)  are virtually identical. 
Another perhaps more useful output of Pixel-based analysis is Pearson’s and 
Manders’ correlation coefficients. However, those results were also inconclusive and 
showed no difference between groups (Table 5 and Table 6). Following Hypothesis 2, 
similar Pearson’s and Manders’ Coefficients were expected between the control and Type 
II comparisons. Higher coefficients were also expected for the Type I comparisons. 
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Instead the results showed no obvious trends between groups, other than the similarities 
between controls. 
Table 5: Pixel-based colocalization results for PCP4 experimental groups. 
Age Comparison mPFC SSp 
Pearson M1 M2 Pearson M1 M2 
P1 
Type I 0.076 0.203 0.068 0.367 0.442 0.352 
Type II 0.007 0.114 0.021 0.018 0.134 0.030 
Control 0.254 0.458 0.232 0.198 0.408 0.154 
P7 
Type I 0.187 0.320 0.163 0.186 0.152 0.371 
Type II 0.116 0.308 0.106 0.059 0.111 0.078 
Control 0.392 0.662 0.331 0.340 0.699 0.218 
Abbreviations: Control, CTIP2/SATB2 comparison; Type I, CTIP2/PCP4 comparison; 
Type II, SATB2/PCP4 comparison; mPFC, Medial prefrontal cortex; SSp, Primary 
somatosensory cortex; Pearson, Pearson’s coefficient; M1, Manders’ coefficient 1; M2, 
Manders’ coefficient. 
 
Table 6: Pixel-based colocalization results for TCERG1L experimental groups. 
Age Comparison mPFC SSp 
Pearson M1 M2 Pearson M1 M2 
P1 
Type I 0.005 0.062 0.037 0.159 0.144 0.340 
Type II 0.009 0.171 0.016 0.335 0.452 0.368 
Control 0.264 0.587 0.215 0.204 0.462 0.160 
P7 
Type I 0.075 0.085 0.157 0.075 0.079 0.171 
Type II 0.488 0.511 0.451 0.287 0.372 0.254 
Control 0.406 0.800 0.257 0.417 0.726 0.300 
Abbreviations: Control, CTIP2/SATB2 comparison; Type I, CTIP2/TCERG1L 
comparison; Type II, SATB2/TCERG1L comparison; mPFC, Medial prefrontal cortex; 
SSp, Primary somatosensory cortex; Pearson, Pearson’s coefficient; M1, Manders’ 
coefficient 1; M2, Manders’ coefficient. 
 
Object-based methods showed cell type specific differences for PCP4. 
Automated cell counts agreed with manual cell counts on 87.5% (28/32 Fisher’s exact 
tests) of experiments. A Chi-square goodness of fit test comparing all manual and 
automated cell counts also showed no significant difference between groups (Χ2=992, X2 
critical=1034, df=961, p=0.237). Power analysis showed that the minimum sample size 
of images required to observe the expected effect size was 18, well below the 42 images 
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quantified for PCP4 and the 45 quantified for TCERG1L. Even at a lower Cohen’s d of 
0.30, the required sample size only increases to 31. This shows that my datasets have 
more than enough power to detect the expected effect sizes (1-β for PCP4: 0.995, 1-β for 
TCERG1L: 0.997). 
The highest colocalization ratio for PCP4 is with the Type I marker (CTIP2), 
whereas colocalization with the Type II marker (SATB2) is comparable to that of the 
control comparison (Table 7). Other than low overall colocalization, there are no 
discernible trends between TCERG1L and either of the Type markers (Table 8). 
Table 7: Object-based colocalization ratio of PCP4+ neurons  
mPFC SSp  
Type I Type II Control Type I Type II Control 
P1 0.763 0.033 0.072 0.572 0.027 0.096 
P7 0.463 0.098 0.122 0.327 0.090 0.144 
The Type I ratio is the highest in each group. The Type II and 
Control ratios are similar. Abbreviations: Type I, CTIP2/PCP4 
comparison; Type II, SATB2/PCP4 comparison; Control, 
CTIP2/SATB2 comparison. 
Table 8: Object-based colocalization ratio of TCERG1L+ neurons  
mPFC SSp  
Type I Type II Control Type I Type II Control 
P1 0.000 0.010 0.073 0.112 0.049 0.098 
P7 0.075 0.168 0.148 0.079 0.065 0.185 
No discernible relationships are present between groups. The 
control ratios are similar to that of PCP4, but higher in all 
groups. Abbreviations: Type I, CTIP2/PCP4 comparison; Type 
II, SATB2/PCP4 comparison; Control, CTIP2/SATB2 
comparison. 
The results of the object-based analyses were conclusive for both putative 
markers. The hypotheses were supported with PCP4 but rejected for TCERG1L. The 
highest ratio of colocalized cells in each age and tissue group was between CTIP2 and 
PCP4, meanwhile SATB2 colocalized with CTIP2 and PCP4 at approximately the same 
rate (Figure 11). Multiple linear regression analysis yielded a statistically significant 
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model overall (F=43.49, R2=0.806, p=1.68x10-13). However, there were no significant 
relationships with age (p=0.192) or brain region (p=0.165). Those non-significant 
variables were removed stepwise and marker type remained as the only significant 
predictor variable of colocalized proportion (F=81.39, R2=0.797, p=1.21x10-14). The 
F-statistic increased from 43.49 to 81.39 after excluding these variables. The R2 only 
dropped from 0.806 to 0.797 showing that the influence of age and region, if any, is 
negligible in comparison to cell type. 
 
Figure 11: Object-based colocalization: PCP4. Type I, CTIP2/PCP4 comparison; Type 
II, SATB2/PCP4 comparison; Control, CTIP2/SATB2 comparison. The whiskers show the 
IQR for each group. Type I colocalization is significantly higher in both age and brain 
regions. 
TCERG1L did not colocalize well with either CTIP2 or SATB2. This held true 
with both age groups and tissue types. There are also no obvious trends in the data and 
much lower overall rates of colocalization, with groups overlapping to a high extent 
(Figure 12). The control groups are similar to that of the PCP4 experiments with median 
values falling somewhere around 0.10 to 0.20. Multiple linear regression analysis also 
yielded a statistically significant model with TCERG1L (F=4.11, R2=0.220, p=0.00702). 
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However, there were no significant differences with brain region (p=0.376) or marker 
type (p=0.0962). 
 
Figure 12: Object-based colocalization: TCERG1L. Type I, CTIP2/ TCERG1L 
comparison; Type II, SATB2/ TCERG1L comparison; Control, CTIP2/SATB2 
comparison. The whiskers show the IQR for each group. 
The linear model for age was also significant (F=10.01, R2=0.17, p=0.00286) as 
was the resulting t-test (t=-3.22, p=0.00244). It is important to realize that these results, 
despite significance, do not support the hypothesis. They are consistent with a slight 
increase in overall positive staining with TCERG1L between the age groups, but there are 
still no significant differences for colocalization with marker types. In other words, these 
results suggest that TCERG1L expression increases with age in these neurons, but does 
not differ between brain region (mPFC vs. SSp) or neuron type (Types I vs. II). 
Overall, PCP4 is a good candidate marker protein worthy of future study. 
TCERG1L does not appear to be so, based on these results. In comparison of pixel-based 
and object-based colocalization analysis that object-based methods were much more 
useful here. Pixel-based methods are easier to implement but more sensitive to the 
different staining patterns of PCP4 and the noisy images of TCERG1L. The development 
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of automated methods was the most technically challenging aspect of this part of the 
project, but ultimately was well worth the effort as it will allow the lab to replicate the 
same analyses on future projects.  
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CHAPTER IV 
CONCLUSIONS 
Neuroinformatics 
H1 The differential gene expression between Type I and Type II neurons is 
indicative of the physiological and morphological differences between the 
two cell types, with expected gene clusters including genes involved with 
neural development and differentiation. 
 
Using Cufflinks and AltAnalyze, we were able to identify fourteen putative cell 
type markers (seven Type I, seven Type II), and some of these putative markers are 
indicative of the functional and morphological differences between Type I and II layer V 
pyramidal neurons of the mouse neocortex, supporting my first hypothesis. Many of the 
genes that are identified as potential targets were previously unknown in association with 
the target cell types or cortical region. For example INHBA is a known marker for 
superficial contralateral projection neurons in layer II/III[2], however it is not mentioned 
in the literature in association with the layer V target cells. Despite this, the data show 
that expression of this gene is elevated in the Type II neurons; which is interesting given 
their shared developmental origins and axonal targets with layer II/III neurons[73]. 
As a basic science approach, an in-silico analysis provides a useful tactic to 
identifying potential phenotypic markers. Even with a low success rate, this approach is 
more efficient than relying on serendipity for finding new markers. Considering the 
stated importance to the discipline of finding new markers for the purpose of defining 
gene signatures[16], this may be one of the most fruitful approaches in this vital work. 
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The lineage profiling identified closely related tissues for both cell types such as 
brain and fetal spinal cord. The highest correlation was seen with neural progenitors and 
visual cortex. Interestingly, neither prefrontal cortex nor somatosensory cortex were 
highlighted. That may be due to a lack of understanding of the developing mouse brain, 
however it may be that it reflects differences in species, as this lineage analysis is 
performed by comparison to a human Wikipathways reference network[74]. A mouse 
reference is not currently available for this feature in AltAnalyze but is under 
development. 
Much of this work is focused on the differences between Type I and II neurons, 
but Ontology analysis helped to highlight the similarities as well. Overall the cell types 
are very similar, which reflects their developmental proximity. Most of the differences in 
Z-score are differences of size not sign. The Z-score gives an idea of how similar the 
gene expression is to a specific tissue type, so a gene with a low Z-score means that it is 
not correlated with that tissue type. In this case, both Type I and II neurons show negative 
Z-scores to several adipose tissue types (perivascular, brown, epididymal and 
subcutaneous), however Type I neurons have more negative Z-scores. The low 
association to adipose tissue is expected because those tissues are different from 
pyramidal neurons functionally as well as ontologically. Conversely, both types show 
positive Z-scores for Bone marrow hematopoietic progenitors and Trophoblast stem cells, 
with Type II neurons showing a larger Z-score in both cases. These associations are 
interesting because they are not functionally similar to pyramidal neurons. However, this 
result suggests that there may be similar pathways utilized in the development of all of 
these tissue types. Again, however, this figure is produced in reference to a human 
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Wikipathways network[74]. Until the same analysis can be performed with a more 
relevant reference, the implications of this result are preliminary. 
Of course, there are differences between Type I and II neurons, as highlighted in 
the results section (Table 3), and those differences are important. The most differentially 
expressed Gene ontology classification was “Negative regulation of axon regeneration”, 
and three of the other top ten ontologies pertain to neural projections of some type. The 
defining feature between these cells is the target of their axons; another well documented 
morphological difference is the geometry and size of their apical dendrites[1]. The online 
DAVID Ontology also yielded results consistent with this, as many of the most highly 
correlated Ontology classifications related to axon guidance or developing neurons. This 
suggests that the genes in this network would be good candidates to explore in future 
studies of this type; especially Pcp4 and the transcription factors Crym, Tcerg1l and 
Lhx2. 
Using the lineage profiling analysis in tandem with the GO-Elite network analysis 
creates a more complete picture. Network analysis reveals the genes at play between 
these two cell types. Both established type markers (Ctip2 and Satb2) are present in the 
gene networks. Most of the putative type markers are also present in one or more of the 
networks. Their presence within the networks supports the other data sources (tissue fate 
network and ontology heatmap) on the importance of these genes in the development of 
the neurons. For example, most of the putative type markers are also identified as 
markers by onboard software in AltAnalyze. 
Some of the genes of interest (Tcerg1l, Shisa2 and Ntng2) are absent from the 
network diagrams. It may be that they are not in the networks because they don’t interact 
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with the other genes. However, it is important to understand that these networks reflect 
the literature. If the genes do not have a strong presence in the literature than they may 
not be in the networks at all. Tcerg1l is differentially expressed in various auditory, motor 
and premotor regions in the primate neocortex[47], and is potentially associated with 
ADHD[50]; but has not been investigated regarding the two layer V neuron types. Ntng2 
is associated with layer specific dendritic development in excitatory neurons of the 
hippocampus and neocortex[13] and is associated with autism[51], but there is also a lack 
of papers looking specifically at Type I and II neurons. Having said that, differential 
expression of the putative type markers, based on what is known about them, would be 
consistent with documented phenotypic differences. 
 Another important consideration is that many of the putative markers are 
transcription factors (Crym, Tcerg1l and Lhx2), and many of the ontologies identified 
through GO-elite and DAVID were associated with transcription regulation of some type. 
This is important because small changes in transcription regulation can potentially lead to 
large phenotypic differences. Since they govern expression of other genes they are the 
most likely gene type to be part of the defining signature for each neuron type. 
Eph receptors (Ephrin receptors) and Plexins (Semaphorin receptors) are two 
other classes of genes that were over represented in the dataset. They are widely 
associated with axon guidance[11], so it is no surprise that they are differentially 
regulated in Type I and II neurons. Eph receptors are the largest known subfamily of 
receptor tyrosine kinases[12] and are membrane bound receptors of Ephrins. Plexins are 
membrane bound receptors of Semaphorins and one of the putative Type II markers, 
Plxna4, belongs to this class of proteins. Both Ephrins and Semaphorins are repulsive 
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signals for the axonal growth cone. Their presence indicates that the developing neurons 
are actively expressing different membrane receptors helping guide them to their 
different targets and are thus critically involved in axonal pathfinding. 
Adding to that, at least four of the fourteen putative type markers are transcription 
factors (Crym, Tcerg1l, Ctip2, Lhx2 and possibly Cux2). Crym, Tcerg1l and Ctip2 are 
Type I markers, while Lhx2 and Cux2 are Type II markers so it is possible that they are 
regulating genes specific to each neuron type. Of these five genes only Ctip2 has been 
shown to functionally regulate axonal development so far[16]. The other four are 
potentially involved in axonal regulation and all four have been observed in either Type I 
or II neurons in other brains regions. 
Colocalization Analysis 
H2 Tissue sections double stained with markers established in the literature 
and the proposed markers, will align with their predicted marker identities 
from Hypothesis 1. 
 
Imaging supported Hypothesis 2 for PCP4 as a type marker independent of age or 
brain region. The fact that it was relatively stable over age and brain region may make it a 
better candidate as a type marker since these neuron types are present throughout the 
many regions of the neocortex and at all ages (Figure 8 and Figure 11). This is as 
opposed to a marker which might have a more ephemeral expression or is sequestered to 
specific regions. It is important to bear in mind that even though it was expressed stably 
between P1 and P7, it may not continue through to adulthood. Future work to assess 
expression in older individuals is essential to better understand the complete 
developmental program. 
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Imaging did not support Hypothesis 2 for TCERG1L; significant results with 
respect to age without a significant relationship for type does not support the hypothesis. 
This only supports the fact that overall expression of TCERG1L increases over the first 
week of postnatal development in the mouse neocortex. Differences in staining between 
medial prefrontal cortex and primary somatosensory cortex at P1 indicates possible 
temporal differences over the course of development. Expression of TCERG1L appears 
to begin earlier in primary somatosensory cortex than in medial prefrontal cortex (Figure 
9 and Figure 12). 
It is possible that TCERG1L is also being expressed in other cell types, for 
example interneurons or glial cells, and that an increase in other cell types is effectively 
washing out the signal from Type I cells. However, the low overall presence of 
TCERG1L+ cells, regardless of whether they colocalize with CTIP2+ or SATB2+ neurons, 
suggests that it is more likely that TCERG1L is merely a poor marker in these ages and 
regions. 
Epitope retrieval for TCERG1L seemed to cause greater background noise and 
non-specific binding of antibodies. Colocalization ratio for TCERG1L controls were 
similar to PCP4 controls but slightly higher in all four experimental groups. While it is 
difficult to make concrete conclusions from these kinds of comparisons; the increase was 
consistent over all experimental groups and both image analysis methodologies. This 
includes the object-based methods, which are not comparing fluorescence intensity but 
spatial relationships of objects in a plane, so they are more robust to noise in the images.  
Object-based methods did partially support my hypotheses for PCP4, but not for 
TCERG1L. For PCP4, colocalization was higher for Type I neurons. The colocalization 
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was highest in medial prefrontal cortex at P1 and lowest in primary somatosensory cortex 
at P7, however the age and region variables were not statistically significant. When the 
non-significant variables are removed stepwise from the model the R2 value will always 
drop some with larger drops indicating larger influences on the model. When the age and 
region variables were removed the R2 only dropped slightly showing that the influence of 
age and region, if any, is negligible in comparison to cell type. This suggests that PCP4 is 
a strong candidate as a new marker type in both regions and age groups. PCP4 has been 
observed in Type I cells of the primary somatosensory cortex[3]. However, this is the 
first evidence that it is also present in the same neuron types of the medial prefrontal 
cortex. 
Despite significant results for multiple regression analysis of TCERG1L 
expression, these results did not support my hypothesis. Only the age variable showed a 
significant relationship and there was no significant relationship between cell types. A 
low R2 and F-statistic also show the weak correlation and small effect size that was 
observed. TCERG1L is therefore not a good candidate marker for these ages or brain 
regions based on these results. 
Pixel-based methods failed to produce useful results for PCP4 in this experiment. 
The method is valid in some cases where fluorescence intensity and staining pattern are 
similar. The benefits of this method are that it is easier to implement and conceptualize 
than object-based methods[36]. The main risk is sensitivity to noise and different staining 
patterns. JACoP and the Pixel intensities code (Appendix C) offered consistent, but 
inconclusive, results. Pearson’s and Manders’ coefficients also showed no correlation. 
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For TCERG1L, these results matched the images. TCERG1L does not appear to 
colocalize with CTIP2 or SATB2 and the pixel-based methods back that up. However, 
background noise may still have affected the results. The results for PCP4 are more likely 
due to limitations of the method and the unsuitability of the images because of 
differences in staining pattern, rather than supporting a lack of evidence. The different 
staining patterns observed here are probably due to functional differences between CTIP2 
and SATB2 (both transcription factors) and PCP4, which is a small cytosolic calmodulin 
binding protein[3,51]. 
Object-based colocalization was clearly a superior methodology in this 
experiment. It is more robust to noise in the images and different staining patterns. Also, 
the results of Χ2 test comparing the Object-based image analysis to that of the manual 
cell counts shows agreement of 87.5% of cases (28/32). The main benefits of automated 
over manual counting is that it provides more objective measures for the colocalization 
that is observed, and vastly reduces the time and effort needed to process the images. 
Automation even helped identify recording errors in manual counts. Originally, the 
manual and automated cell counts only agreed in 75% (24/32) of images. Upon 
reexamining the data, a recording error in four of the data points were discovered. Fixing 
these errors increased the agreement between methods by 12.5%. 
Just as great of a benefit is the increase in processing time. The automation 
process is still very labor intensive. Several weeks of troubleshooting, testing and 
streamlining were needed to create a useable automated process. Experience with image 
processing, programming and statistical analysis is beneficial, maybe even obligatory, to 
adequately execute this type of analysis. However, after the protocol was established a 
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total of three hours was all that was needed to process more than double the images that 
took three and a half weeks of manual counting. A unique protocol must be created for 
each set of experiments because of the differences between IHC protocols and high 
inherent variability microscopy images[23,34]; but the protocol may be altered for future 
studies fairly easily. So, the return on investment of time and effort is outstanding. 
A Note of Caution 
One of the major considerations about this project is that many of the putative 
marker genes identified may not be expressed in the adult mouse tissue. Many of the 
differentially expressed genes in the dataset are related to developmental processes, 
especially those identified as potential targets[17,75]. Therefore, the developmental time 
course of this study will help fill in part of the gaps between P1 and the adult mouse, 
providing a valuable characterization of the gene expression changes that are responsible 
for the maturation of layer V neurons in the mouse medial prefrontal and primary 
somatosensory cortices. I have also identified elevated or down-regulated gene clusters 
that are associated with various developmental processes. 
Lineage profiling included apparently different cell types. The pathways merely 
reflect those that are annotated in the database from the literature[74]. Our current 
knowledge poses no limitation to biology though, so nothing precludes nature from using 
these genes for alternative purposes in the body; examples of gene pleiotropy are quite 
common. It is presumed here that these pathways are serving some other purpose that is 
important to the development of these cell types.  
The negative results of six of the eight putative markers is problematic. Every 
effort was made to optimize the use of the antibodies to obtain positive staining. Many 
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multiple permutations of antibody concentration, incubation time, incubation 
temperature, fixation methodology and epitope retrieval were tried for every antibody. 
None of these permutations yielded positive staining for those six antibodies. 
There are two possibilities for why so many of the experiments resulted in failure. 
First, there was no positive staining because the antibodies were faulty. Second, there was 
no positive staining because the binding epitope was not available. The two causes end 
with the same result and are therefore indistinguishable from each other. If the first 
possibility is the case, then it might be rectified by merely purchasing another antibody 
(if available) or using another method, such as in situ hybridization (which would not 
observe protein expression). 
If the latter reason is the cause then another problem arises, there are many 
possible sources for this issue. Our original dataset is based on RNA-seq, which uses 
chiefly mRNA, but the immunohistochemistry protocol uses antibodies specific to 
expressed proteins. There are many molecular steps between the two, and an interruption 
of any of those steps could result in the epitope not being present for the antibody to bind. 
While the genes identified in the analyses may be differentially expressed, their 
respective proteins may not be. The mRNA may not be translated to protein at all. Even if 
translated, a fully mature protein often requires post-translational modification, such as 
some form of glycosylation. The protein may be sequestered in a vesicle, transported far 
away from the soma, rapidly degraded or present in too small of quantities to be observed 
via this methodology. The epitope could even be masked by fixation or destroyed by 
epitope retrieval. These are all possible issues with immunohistochemistry, and they all 
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produce identical results to a faulty antibody. In light of this it is important to 
acknowledge that the negative results with these antibodies are not conclusive. 
Future Work 
The methodology outlined here lays the framework for many future related 
studies utilizing other publicly available datasets. Indeed, the same dataset could be used 
to make similar comparisons between the two neuron types and Layer VI pyramidal 
neurons. Comparison of superficial (layer II/III) and deep (layer V) contralateral 
projection neurons would be possible with the dataset from another similar paper[18]. 
This methodology requires relatively little resources and could be performed utilizing 
common techniques such as immunohistochemistry and open source software on 
moderately powerful servers. 
The same methodology could be used to perform similar studies in different ages 
and brain regions. Perhaps the key to understanding brain regionalization rests in 
deciphering differential gene expression between regions. Also, the neurons are not fully 
matured for several weeks after this time period, so this project could be expanded upon 
to observe changes in gene signatures through to adulthood, which is work that is 
currently underway in our lab. This might shed light on previously unobserved ion 
channels, for example, which could affect the electrophysiological behavior of the mature 
neurons. 
Different methods for assessing expression of genes such as in situ hybridization 
or developmental studies involving the putative markers will be essential to 
understanding their role in the developing neurons. This is difficult because a knockout or 
mutation of some of these genes is fatal, for example CTIP2 knockout mice 
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spontaneously expire at birth[3] as do SATB2 knockouts[25]. These methods could also 
be used on animal models of brain disorders to help highlight affected genes and gene 
clusters. 
The mouse remains an effective animal model for brain function and 
development, but there are well known differences between the mouse and primate 
neocortex. Type I and II neurons specifically are larger and more numerous with more 
elaborate neuronal projection morphologies[10]. This characteristic is even more 
pronounced in the human brain. Since many of the most common gene clusters 
recognized in my analysis involved neural projection regulatory genes, the basis of our 
superior mental abilities may be in evolutionary differences in some of the very genes 
identified in this project. Srgap2 for example, which regulated dendritic spine formation 
and is evolutionarily important in the human neocortex[76,77], is expressed 1.4 times 
higher in Type II neurons in my dataset. Too small of a difference to be identified as a 
putative marker in this protocol, but a statistically significant difference nonetheless 
(p=0.00564). 
As is often the case in basic biology, the results here open more questions than 
they close. There are many possible future directions to expand on this project, especially 
when taken in concert with the larger body of research on this subject that is currently 
underway by multiple labs doing similar studies, mostly at younger ages and other brain 
regions. The main contribution here is expanding this line of research into postnatal ages 
and to the medial prefrontal cortex. It is critical for this work to continue as these results 
suggest that the genes involved continue to change throughout these age groups, and 
there are clearly developmental differences between regions. 
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APPENDIX C 
COLOCALIZATION PROTOCOL 
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Colocalization_Protocol.ijm 
// This ImageJ macro will run the Complex Mask Batch macro, preprocessing all images 
in the source folder for pixel based colocalization. It then batch processes all output 
images of the complex mask through the Pixel Intensities macro. After collecting all of 
the pixel intensity data for an image it saves the results table in a .csv file in the same 
directory for future statistical analysis. It then calls the JACoP plugin to run 
colocalization analysis on each output file from the Complex Mask Batch macro and calls 
upon the use to save the output files. Save this file into the Macros or Plugins folder in 
ImageJ and it will show up in the corresponding menu of the GUI. 
 
// Runs Complex Mask Batch macro to open each tif image file in the selected input 
folder and saves that output to the selected output folder. 
run("Complex Mask Batch"); 
 
// Prompts user to select an input folder with tif image files for Pixel Intensity macro and 
JACoP plugin 
input = getDirectory("Select input directory for Pixel Intensity and JACoP"); 
Dialog.create("Select file type for Pixel Intensity and JACoP"); 
Dialog.addString("File suffix: ", ".tif", 5); 
Dialog.show(); 
suffix = Dialog.getString(); 
 
// Prompts user to select an output folder for .csv file output of Pixel Intensity macro 
output = getDirectory("Select output directory for Pixel Intensity and JACoP"); 
 
// Opens the folder, assigns each file a position in the file list for processing, then calls 
intenseFile function for each file 
function intenseFolder(input) { 
    list = getFileList(input); 
    for (i = 0; i < list.length; i++) { 
        if(File.isDirectory(list[i])) 
            intenseFolder("" + input + list[i]); 
        if(endsWith(list[i], suffix)) 
            intenseFile(input, output, list[i]); 
    } 
} 
 
// Opens each image individually, runs Pixel Intensity macro on open image, saves each 
.csv file to the output directory 
function intenseFile(input, output, file) { 
 
 print("Intensifying: " + input + file); 
    open(input + file); 
    //waitForUser("Spot check", "Is this working?"); 
     name = getTitle; 
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     dotIndex = indexOf(name, "."); 
  name = substring(name, 0, dotIndex); 
  // Separates channels and renames them, a Gaussian blur is applied to red 
and green channels at a sigma of half the diameter of smallest object of interest. 
  run("Stack to Images"); 
  name1 = name + "-0001"; 
  selectWindow(name1); 
  rename("result1"); 
  run("Gaussian Blur...", "sigma=10"); 
  name2 = name + "-0002"; 
  selectWindow(name2); 
  rename("result2"); 
  run("Gaussian Blur...", "sigma=10"); 
  name3 = name + "-0003"; 
  selectWindow(name3); 
  rename("result3"); 
  run("Merge Channels...", "c1=result1 c2=result2 c3=result3 create"); 
  selectWindow("Composite"); 
  run("RGB Color"); 
      
  run("Pixel Intensities"); 
   
  saveAs("Results",  output + name + ".csv"); // caution: this will overwrite 
any files with the same name currently in the output folder 
 
    close(); 
    run("Close all windows"); 
    //waitForUser("Spot check", "Is this working?"); 
} 
 
intenseFolder(input); 
waitForUser("Finished", "Processing pixel intensities of all files in the folder is 
finished."); 
 
// Opens the folder, assigns each file a position in the file list for processing, then calls 
jacopFile function for each file 
function jacopFolder(input) { 
    list = getFileList(input); 
    for (i = 0; i < list.length; i++) { 
        if(File.isDirectory(list[i])) 
            jacopFolder("" + input + list[i]); 
        if(endsWith(list[i], suffix)) 
            jacopFile(input, output, list[i]); 
    } 
} 
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// Opens each image individually, runs JACoP plugin on open image, saves Log to the 
output directory and prompts user to save other relevant files to output 
function jacopFile(input, output, file) { 
 
 print("\\Clear"); // Clears the Log window. 
 print("JACing oP: " + input + file); 
    open(input + file); 
    //waitForUser("Spot check", "Is this working?"); 
  
     name = getTitle; 
     dotIndex = indexOf(name, "."); 
  name = substring(name, 0, dotIndex); 
 
  // Create a directory with the images name 
    dir = name+File.separator; 
    File.makeDirectory(output + dir); 
    print(""); 
    print(dir); 
 
  // Separates channels of input image, red and green channels are used for 
colocalization 
  run("Stack to Images"); 
  name1 = name + "-0001"; 
  selectWindow(name1); 
  rename("result1"); 
  name2 = name + "-0002"; 
  selectWindow(name2); 
  rename("result2"); 
  //waitForUser("Spot check", "Is this working?"); 
 
  run("JACoP ", "imga=result1 imgb=result2 thra=2 thrb=2 pearson overlap 
mm cytofluo objdist=500-8000-158.57142857142858-396.4285714285715-true-true-true 
objcentpart=500-8000-true-true-true"); 
  selectWindow("Log"); 
  saveAs("text",  output + dir + name + ".txt"); // caution: this will 
overwrite any files with the same name currently in the output folder 
  //waitForUser("Spot check", "Is this working?"); 
  waitForUser("JACoP", "Save output files"); // Waits for user input before 
finishing colocalization analysis on this image 
   
    run("Close all windows"); 
    //waitForUser("Spot check", "Is this working?"); 
} 
 
jacopFolder(input); 
waitForUser("Finished", "Colocalization analysis of all files in the folder is finished."); 
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// Batch processing retrieved and modified from 
http://imagej.net/Scripting_toolbox#Opening.2C_processing.2C_and_saving_a_sequence
_of_files_in_a_folder 
 
// Save output to .csv file retrieved and modified from code found at: 
http://imagej.1557.x6.nabble.com/save-results-table-as-csv-with-custom-name-
td5003427.html 
 
// Cobbled together by Ryan Pevey 26/8/2016, feel free to contact with further questions 
bioryguy@gmail.com 
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APPENDIX E 
COMPLEX MASK 
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Complex_Mask.ijm 
// This ImageJ macro will take an open three channel image stack, split it into its 
constituent channels, subtract the background through a complex mask before stitching 
the channel back together as an RGB rendered image. The first channel will be red, then 
blue, then green. The complex mask is really a simple threshold, determined by the user, 
and subtracted from the original channel. Save this file into the Macros or Plugins folder 
in ImageJ and it will show up in the corresponding menu of the GUI. 
 
//open("C:\\Users\\PhilFry\\Desktop\\4CH\\Test\\CZI\\PCP4_4CHP1_2016_05_31__11_
37_57(1)TypeI.tif"); 
 
// Obtain the name of the open file, then convert the stack to three separate images for 
individual processing 
name = getTitle; 
dotIndex = indexOf(name, "."); 
name = substring(name, 0, dotIndex); 
run("Stack to Images"); 
 
// Select Red channel and ask user for threshold input, then create a mask and subtract it 
from original to subtract background 
name1 = name + "-0001"; 
selectWindow(name1); 
run("Despeckle"); 
run("Duplicate...", " "); 
selectWindow(name1 + "-1"); 
run("Threshold..."); // This line can be modified to use any of the built-in threshold 
algorithms for faster, more automated image processing 
setOption("BlackBackground", false); 
waitForUser("Threshold", "Select threshold settings"); // Waits for user input before 
finishing image processing on this channel 
run("Convert to Mask"); 
run("Close"); 
run("Despeckle"); 
run("Dilate"); 
run("Invert"); 
imageCalculator("Subtract create", name1, name1 + "-1"); 
name1_1 = "Result of " + name1; 
selectWindow(name1_1); 
rename("result1"); 
run("Enhance Contrast...", "saturated=0.4"); 
 
// Select Green channel and ask user for threshold input, then create a mask and subtract 
it from original to subtract background 
name2 = name + "-0002"; 
selectWindow(name2); 
88 
 
  
run("Despeckle"); 
run("Duplicate...", " "); 
selectWindow(name2 + "-1"); 
run("Threshold..."); 
setOption("BlackBackground", false); 
waitForUser("Threshold", "Select threshold settings"); 
run("Convert to Mask"); 
run("Close"); 
run("Despeckle"); 
run("Dilate"); 
run("Invert"); 
imageCalculator("Subtract create", name2, name2 + "-1"); 
name2_1 = "Result of " + name2; 
selectWindow(name2_1); 
rename("result2"); 
run("Enhance Contrast...", "saturated=0.4"); 
 
// Select Blue channel and ask user for threshold input, then create a mask and subtract it 
from original to subtract background 
name3 = name + "-0003"; 
selectWindow(name3); 
run("Despeckle"); 
run("Duplicate...", " "); 
selectWindow(name3 + "-1"); 
run("Threshold..."); 
setOption("BlackBackground", false); 
waitForUser("Threshold", "Select threshold settings"); 
run("Convert to Mask"); 
run("Close"); 
run("Despeckle"); 
run("Dilate"); 
run("Invert"); 
imageCalculator("Subtract create", name3, name3 + "-1"); 
name3_1 = "Result of " + name3; 
selectWindow(name3_1); 
rename("result3"); 
run("Enhance Contrast...", "saturated=0.4"); 
 
// Combine images to create RGB render 
run("Merge Channels...", "c1=result1 c2=result2 c3=result3 create"); 
selectWindow("Composite"); 
run("RGB Color"); 
 
// Close all windows 
//run("Close all windows"); 
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// Complex mask procedure modified from http://imagej.net/Image_Intensity_Processing 
 
// Cobbled together by Ryan Pevey 26/8/2016, feel free to contact with further questions 
bioryguy@gmail.com 
 
Complex_Mask_Batch.ijm 
 
// This ImageJ macro batch processes all of the files of an input folder for future image 
analysis. It calls on the user to select an input directory with .tif files to process, and an 
output directory for the processed files to go into after completion. It will then open each 
tif file in the input directory and run the Complex Mask macro on every one in turn 
before signifying completion of the processing to the user. Save this file into the Macros 
or Plugins folder in ImageJ and it will show up in the corresponding menu of the GUI. 
 
// Select input and output directories 
input = getDirectory("Select input directory for Complex Mask"); 
output = getDirectory("Select output directory for Complex Mask"); // output 
directory should be different from parent directory or original files will be overwritten 
 
// Establish file type for batch processing 
Dialog.create("Select file type for Complex Mask"); 
Dialog.addString("File suffix: ", ".tif", 5); 
Dialog.show(); 
suffix = Dialog.getString(); 
 
// Opens the folder, assigns each file a position in the file list for processing, then calls 
processFile function for each file 
function processFolder(input) { 
    list = getFileList(input); 
    for (i = 0; i < list.length; i++) { 
        if(File.isDirectory(list[i])) 
            processFolder("" + input + list[i]); 
        if(endsWith(list[i], suffix)) 
            processFile(input, output, list[i]); 
    } 
} 
 
// Opens each image individually, runs Complex Mask macro on open image, saves each 
processed image to the output directory 
function processFile(input, output, file) { 
 
 print("Processing: " + input + file); 
    open(input + file); 
    //waitForUser("Spot check", "Is this working?"); 
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  run("Complex Mask"); 
  
 selectWindow("Composite"); 
 //waitForUser("Spot check", "Is this working?"); 
 rename(input + file); 
    print("Saving to: " + output); 
    saveAs("TIFF", output+file); 
    //waitForUser("Spot check", "Is this working?"); 
    close(); 
    run("Close all windows"); 
} 
 
processFolder(input); 
waitForUser("Finished", "Complex masking of all files in the folder is finished."); 
 
// Batch processing retrieved and modified from 
http://imagej.net/Scripting_toolbox#Opening.2C_processing.2C_and_saving_a_sequence
_of_files_in_a_folder 
 
// Cobbled together by Ryan Pevey 26/8/2016, feel free to contact with further questions 
bioryguy@gmail.com 
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APPENDIX F 
PIXEL INTENSITIES 
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Pixel_Intensities.ijm 
// This ImageJ macro will take any 24 bit RGB image and return the individual pixel 
intensity values for each channel. First, it obtains the intensity data for each pixel 
individually. Then extracts each channel intensity from the raw hexadecimal pixel data. If 
any of the three values is greater than the stated threshold it then stores it in the Results 
table with that pixels corresponding (x and y) coordinates, "raw" hexadecimal value and 
blue channel value. It can then prompt the user to decide which folder to save the .csv 
results file to and automatically name this output file after the parent image. Save this file 
into the Macros or Plugins folder in ImageJ and it will show up in the corresponding 
menu of the GUI. 
 
//open("C:\\Users\\PhilFry\\Desktop\\4CH\\Test\\CZI\\PCP4_4CHP1_2016_05_31__11_
37_57(1)TypeI.tif"); 
 
// Obtain pixel height and width of image. 
h=getHeight(); 
w=getWidth(); 
t=0; // Threshold value for blue channel, valid values are between 0 and 255. If blue 
channel is thresholded as binary this value should be 0. 
//i=50; 
//j=50; 
if (nResults>=0) run("Clear Results"); // Check whether the results table is empty, 
if not clear it. 
// Obtain RGB pixel intensity value for each pixel individually. 
for (i=0; i<w; i++){ 
     for (j=0; j<h; j++){ 
          c = getPixel(i, j); 
          //c=getPixel(730,20) 
          // Pixel data (c) is stored in hexadecimal format so the channels are extracted 
below. 
    b = c&0xff; // extract blue byte (bits 7-0) 
    r = (c>>16)&0xff; // extract red byte (bits 23-17) 
    g = (c>>8)&0xff; // extract green byte (bits 15-8) 
          if (r>t||g>t) { // only extract pixel data if at least one channel intensity is greater 
than threshold 
           k = nResults; 
           //r = (c>>16)&0xff; // extract red byte (bits 23-17) 
     //g = (c>>8)&0xff; // extract green byte (bits 15-8) 
     // add pixel data to Result table 
     setResult("x", k, i); 
     setResult("y", k, j); 
     setResult("Raw", k, c); 
     setResult("Red", k, r); 
     setResult("Green", k, g); 
     setResult("Blue", k, b); 
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     // print(nResults,c,r,g,b); 
    } 
     } 
 } 
updateResults(); 
print(nResults); 
 
// Save output to .csv file 
/*dir = getDirectory("Select a directory"); 
name = getTitle; 
dotIndex = indexOf(name, "."); 
name = substring(name, 0, dotIndex); 
saveAs("Results",  dir + name + ".csv"); // caution: this will overwrite any files with 
the same name currently in the output folder 
 
// For more info on hexadecimal extraction of pixel intensities see: 
http://crazybiocomputing.blogspot.com/2011/11/exploring-colors-and-grays-with-
imagej.html or http://imagej.1557.x6.nabble.com/setPixel-and-getPixel-for-RBG-images-
td5007241.html 
 
// Save output to .csv file retrieved and modified from code found at: 
http://imagej.1557.x6.nabble.com/save-results-table-as-csv-with-custom-name-
td5003427.html 
 
// Adding data to Results table: http://image-
stack.de/IIP%20with%20ImageJ/CHAPTER01/CHAPTER01-3/chapter01-3.html 
 
// Cobbled together by Ryan Pevey 23/8/2016, feel free to contact with further questions 
bioryguy@gmail.com 
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MANUAL VS AUTOMATIC CELL COUNTS 
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manVauto.R 
dat <- read.csv("C:/Users/PhilFry/Desktop/4CH/manVauto.csv") 
 
# The doIt function takes the row of dat as an argument and constructs a 2by2 table using 
the appropriate columns depending on dat$type. It then performs a Fisher's exact test to 
determine statistical significance.  
doIt <- function(r) { 
  if (dat[r,2]=="1mPFC1" || dat[r,2]=="1SMS1" || dat[r,2]=="7mPFC1" || 
dat[r,2]=="7SMS1") { 
    fish <- as.data.frame(cbind(dat[r,3],dat[r,4])) 
    fish[2,] <- cbind(dat[r,5],dat[r,6]) 
  } 
  else  { 
     
    if (dat[r,2]=="1mPFC2" || dat[r,2]=="1SMS2" || dat[r,2]=="7mPFC2" || 
dat[r,2]=="7SMS2") { 
      fish <- as.data.frame(cbind(dat[r,3],dat[r,4])) 
      fish[2,] <- cbind(dat[r,7],dat[r,8]) 
    } 
   
    else  { 
      fish <- as.data.frame(cbind(dat[r,3],dat[r,4])) 
      fish[2,] <- cbind(dat[r,7],dat[r,9]) 
    } 
  } 
  print(fish) 
  fisher.test(fish) 
} 
 
doIt(1) 
 
# for test purposes of the doIt function, the tst function performs the same operation as 
above with four integers as arguments specified by the user. 
tst <- function(a,b,c,d) { 
  fish <- as.data.frame(cbind(a,b)) 
  fish[2,] <- cbind(c,d) 
  print(fish) 
  fisher.test(fish) 
} 
 
tst(9,216,3,124) 
 
 
### Read the dataset into R. Out.csv was automatically extracted from colocalization 
protocol log files, marker and type columns added manually for processing. 
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summary(dat) 
summary(dat$type) 
 
 
# Create an empty data frame 
chi <- data.frame(manCo=numeric(), manNon=numeric(), autCo=numeric(), 
autNon=numeric()) 
 
 
# Subset the dat dataset and fill in colocalized and non-colocalized depending on type 
for (i in 1:nrow(dat)) { 
  if (dat[i,2]=="1mPFC1" || dat[i,2]=="1SMS1" || dat[i,2]=="7mPFC1" || 
dat[i,2]=="7SMS1") { 
    chi[i,] <- as.data.frame(cbind(dat[i,3],dat[i,4],dat[i,5],dat[i,6]), stringsAsFactors = 
FALSE) #centANum, centADen 
  } 
  else  { 
     
    if (dat[i,2]=="1mPFC2" || dat[i,2]=="1SMS2" || dat[i,2]=="7mPFC2" || 
dat[i,2]=="7SMS2") { 
      chi[i,] <- as.data.frame(cbind(dat[i,3],dat[i,4],dat[i,7],dat[i,8]), stringsAsFactors = 
FALSE) #centBNum, centBDen 
    } 
     
    else  { 
      chi[i,] <- as.data.frame(cbind(dat[i,3],dat[i,4],dat[i,7],dat[i,9]), stringsAsFactors = 
FALSE) #centBNum, totNon 
    } 
  } 
} 
 
summary(chi) 
chi 
 
### Chi-square goodness of fit 
 
chisq.test(chi$manCo/chi$manNon,chi$autCo/chi$autNon) 
 
# Cobbled together by Ryan Pevey 3/9/2016, feel free to contact with further questions 
bioryguy@gmail.com 
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APPENDIX H 
FIGURE CREATION AND STATISTICAL ANALYSIS 
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ex.R 
# This script processes the ex master dataset; it is partnered with the autCount.R script. 
All figure creation and final processing is performed in this script. 
 
# Define PCP4 subsets 
pcp <- subset(ex, ex$marker == "PCP4") 
pcp1 <- subset(pcp, pcp$age == "p1") 
pcp7 <- subset(pcp, pcp$age == "p7") 
summary(pcp) 
 
pcp1m <- subset(pcp1, pcp1$tissue == "mPFC") 
pcp1s <- subset(pcp1, pcp1$tissue == "SMS") 
pcp7m <- subset(pcp7, pcp7$tissue == "mPFC") 
pcp7s <- subset(pcp7, pcp7$tissue == "SMS") 
 
# Define TCERG1L subsets 
tce <- subset(ex, ex$marker == "TCERG1L") 
tce1 <- subset(tce, tce$age == "p1") 
tce7 <- subset(tce, tce$age == "p7") 
summary(tce) 
 
tce1m <- subset(tce1, tce1$tissue == "mPFC") 
tce1s <- subset(tce1, tce1$tissue == "SMS") 
tce7m <- subset(tce7, tce7$tissue == "mPFC") 
tce7s <- subset(tce7, tce7$tissue == "SMS") 
 
# Plots 
library(lattice) 
library(ggplot2) 
 
# PCP4 plots 
plot(pcp$colocal/pcp$noncoloc~pcp$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "All PCP4") 
plot(pcp1$colocal/pcp1$noncoloc~pcp1$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "P1 PCP4") 
plot(pcp7$colocal/pcp7$noncoloc~pcp7$exp, xlab = "Cell type", ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "P7 PCP4") 
plot(pcp1m$colocal/pcp1m$noncoloc~pcp1m$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at 
P1 in mPFC") 
plot(pcp1s$colocal/pcp1s$noncoloc~pcp1s$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at 
P1 in SSp") 
99 
 
  
plot(pcp7m$colocal/pcp7m$noncoloc~pcp7m$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at 
P7 in mPFC") 
plot(pcp7s$colocal/pcp7s$noncoloc~pcp7s$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at 
P7 in SSp") 
 
par(xpd=TRUE) 
plot(pcp$colocal/pcp$noncoloc~pcp$type, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", 
"Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control"), main = "Object based 
PCP4 colocalization", las = 2) 
  mtext("P1", side = 3, line = 0, adj = 0.25) 
  mtext("P7", side = 3, line = 0, adj = 0.75) 
  mtext("mPFC", side = 1, line = 4, adj = 0.125) 
  mtext("SSp", side = 1, line = 4, adj = 0.375) 
  mtext("mPFC", side = 1, line = 4, adj = 0.625) 
  mtext("SSp", side = 1, line = 4, adj = 0.875) 
 
  segments(x0=6.5, y0=0.0, x1=6.5, y1=0.8) 
  segments(x0=3.5, y0=0.0, x1=3.5, y1=0.8, lty = 2) 
  segments(x0=9.5, y0=0.0, x1=9.5, y1=0.8, lty = 2) 
   
  segments(x0=0.75,y0=-0.39,x1=0.75,y1=-0.42) 
  segments(x0=3.25,y0=-0.39,x1=3.25,y1=-0.42) 
  segments(x0=0.75,y0=-0.42,x1=3.25,y1=-0.42) 
 
  segments(x0=3.75,y0=-0.39,x1=3.75,y1=-0.42) 
  segments(x0=6.25,y0=-0.39,x1=6.25,y1=-0.42) 
  segments(x0=3.75,y0=-0.42,x1=6.25,y1=-0.42) 
 
  segments(x0=6.75,y0=-0.39,x1=6.75,y1=-0.42) 
  segments(x0=9.25,y0=-0.39,x1=9.25,y1=-0.42) 
  segments(x0=6.75,y0=-0.42,x1=9.25,y1=-0.42) 
 
  segments(x0=9.75, y0=-0.39, x1=9.75, y1=-0.42) 
  segments(x0=12.25, y0=-0.39, x1=12.25, y1=-0.42) 
  segments(x0=9.75, y0=-0.42, x1=12.25, y1=-0.42) 
 
 
plot(pcp$thrM1~pcp$type, xlab = NULL, ylab = NULL, names = c("Type 1", "Type 2", 
"Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", 
"Type 2", "Control"), main = "Proportion of Ch 1 colocalized with Ch 2", las = 2) 
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plot(pcp$thrM2~pcp$type, xlab = NULL, ylab = NULL, names = c("Type 1", "Type 2", 
"Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", 
"Type 2", "Control"), main = "Proportion of Ch 2 colocalized with Ch 1", las = 2) 
 
#plot(pcp1$colocal/pcp1$noncoloc~pcp1$type, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", 
"Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control"), main = "P1 PCP4", las = 
2) 
 
bwplot(pcp$colocal/pcp$noncoloc~pcp$exp | factor(pcp$age)) 
 
#ggplots 
qplot(pcp$exp, pcp$colocal/pcp$noncoloc, geom = "boxplot", xlab = "Cell type", ylab = 
"Proportion Colocalized", main = "All PCP4") 
qplot(pcp1$exp, pcp1$colocal/pcp1$noncoloc, geom = "boxplot", xlab = "Cell type", 
ylab = "Proportion Colocalized") 
qplot(pcp7$exp, pcp7$colocal/pcp7$noncoloc, geom = "boxplot", xlab = "Cell type", 
ylab = "Proportion Colocalized") 
#qplot(pcp$exp, pcp$colocal/pcp$noncoloc) + geom_jitter(height = 0.1, width = 0.1) 
myPlot<-qplot(x=pcp$exp,y=pcp$colocal/pcp$noncoloc, geom = "boxplot" , 
fill=pcp$exp) 
#myPlot + theme_dark() + theme(legend.position='none') 
#myPlot + theme(panel.background=element_rect(fill='black')) 
#myPlot + annotate("text", x = 2, y = max(pcp$colocal/pcp$noncoloc), label = 
"Relationship between x and y") 
 
ggplot(data = pcp1, aes(x=exp, y=colocal/noncoloc)) + geom_boxplot(aes(fill=tissue)) 
 
 
#qplot(pcp$exp, pcp$colocal/pcp$noncoloc) + geom_jitter(height = 0.1, width = 0.1) 
 
 
#TCERG1L Plots 
 
plot(tce$colocal/tce$noncoloc~tce$exp, xlab = "Cell type", ylab = "Proportion 
Colocalized", las = 2) 
plot(tce1$colocal/tce1$noncoloc~tce1$exp, xlab = "Cell type", ylab = "Proportion 
Colocalized", las = 2) 
plot(tce7$colocal/tce7$noncoloc~tce7$exp, xlab = "Cell type", ylab = "Proportion 
Colocalized", las = 2) 
plot(tce1m$colocal/tce1m$noncoloc~tce1m$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L 
colocalization at P1 in mPFC") 
plot(tce7m$colocal/tce7m$noncoloc~tce7m$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L 
colocalization at P7 in mPFC") 
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plot(tce1s$colocal/tce1s$noncoloc~tce1s$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L 
colocalization at P1 in SSp") 
plot(tce7s$colocal/tce7s$noncoloc~tce7s$exp, xlab = NULL, ylab = "Proportion 
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L 
colocalization at P7 in SSp") 
 
par(xpd=TRUE) 
plot(tce$colocal/tce$noncoloc~tce$type, xlab = NULL, ylab = "Proportion Colocalized", 
names = c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", 
"Type 2", "Control", "Type 1", "Type 2", "Control"), main = "Object based TCERG1L 
colocalization", las = 2) 
  mtext("P1", side = 3, line = 0, adj = 0.25) 
  mtext("P7", side = 3, line = 0, adj = 0.75) 
  mtext("mPFC", side = 1, line = 4, adj = 0.125) 
  mtext("SSp", side = 1, line = 4, adj = 0.375) 
  mtext("mPFC", side = 1, line = 4, adj = 0.625) 
  mtext("SSp", side = 1, line = 4, adj = 0.875) 
 
  segments(x0=6.5, y0=0.0, x1=6.5, y1=0.3) 
  segments(x0=3.5, y0=0.0, x1=3.5, y1=0.3, lty = 2) 
  segments(x0=9.5, y0=0.0, x1=9.5, y1=0.3, lty = 2) 
 
  segments(x0=0.75,y0=-0.14,x1=0.75,y1=-0.155) 
  segments(x0=3.25,y0=-0.14,x1=3.25,y1=-0.155) 
  segments(x0=0.75,y0=-0.155,x1=3.25,y1=-0.155) 
 
  segments(x0=3.75,y0=-0.14,x1=3.75,y1=-0.155) 
  segments(x0=6.25,y0=-0.14,x1=6.25,y1=-0.155) 
  segments(x0=3.75,y0=-0.155,x1=6.25,y1=-0.155) 
 
  segments(x0=6.75,y0=-0.14,x1=6.75,y1=-0.155) 
  segments(x0=9.25,y0=-0.14,x1=9.25,y1=-0.155) 
  segments(x0=6.75,y0=-0.155,x1=9.25,y1=-0.155) 
 
  segments(x0=9.75, y0=-0.14, x1=9.75, y1=-0.155) 
  segments(x0=12.25, y0=-0.14, x1=12.25, y1=-0.155) 
  segments(x0=9.75, y0=-0.155, x1=12.25, y1=-0.155) 
 
plot(tce$thrM1~tce$type, xlab = NULL, ylab = "Proportion Colocalized", names = 
c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2", 
"Control", "Type 1", "Type 2", "Control"), main = "Proportion of Ch 1 colocalized with 
Ch 2", las = 2) 
plot(tce$thrM2~tce$type, xlab = NULL, ylab = "Proportion Colocalized", names = 
c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2", 
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"Control", "Type 1", "Type 2", "Control"), main = "Proportion of Ch 2 colocalized with 
Ch 1", las = 2) 
 
#ggplots 
qplot(tce$exp, tce$colocal/tce$noncoloc, geom = "boxplot", xlab = "Cell type", ylab = 
"Proportion Colocalized") 
qplot(tce1$exp, tce1$colocal/tce1$noncoloc, geom = "boxplot", xlab = "Cell type", ylab 
= "Proportion Colocalized") 
qplot(tce7$exp, tce7$colocal/tce7$noncoloc, geom = "boxplot", xlab = "Cell type", ylab 
= "Proportion Colocalized") 
 
 
#####Statistical analysis 
pcpLM <- lm(colocal/noncoloc ~ age + tissue + exp, data = pcp) 
summary(pcpLM) 
anova(pcpLM) 
plot(pcpLM) 
confint(pcpLM) 
pcp.aov <- aov(colocal/noncoloc ~ age + tissue + exp, data = pcp) 
summary(pcp.aov) 
TukeyHSD(pcp.aov) 
 
pairs(~colocal/noncoloc+age+tissue+exp, data = pcp) 
 
tceLM <- lm(colocal/noncoloc ~ age + tissue + exp, data = tce) 
summary(tceLM) 
anova(tceLM) 
plot(tceLM) 
confint(tceLM) 
tce.aov <- aov(colocal/noncoloc ~ age + tissue + exp, data = tce) 
summary(tce.aov) 
TukeyHSD(tce.aov) 
 
#Power analysis 
library(pwr) 
###Calculate needed sample size 
cohen.ES(test = c("anov"),size = c("large")) 
pwr.anova.test(k=4,f=0.40,sig.level=0.05,power=0.8) 
pwr.anova.test(k=4,f=0.30,sig.level=0.05,power=0.8) 
pwr.anova.test(k=4,n=42,f=0.40,sig.level=0.05) 
pwr.anova.test(k=4,n=45,f=0.40,sig.level=0.05) 
 
# Cobbled together by Ryan Pevey 20/9/2016, feel free to contact with further questions 
bioryguy@gmail.com 
